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Summary 
 
This main aim of this study was to assess patients in a general cardiology practice in order to 
determine the systolic and diastolic profiles of these patients. The aim was also to determine 
what effect life style and risk factors may have on the echocardiographic variables measured 
during such an examination. The specific aim of this study was the importance of not only 
examining the systolic function but the necessity to also examine the diastolic profile of 
patients. Life-style plays an important role, with the main culprit being obesity. Obesity was 
the single most important factor that affected the diastolic profile of patients seen in this 
study. With obesity a combination of other risk factors related to obesity was observed. Most 
abnormalities found due to these risk factors were associated with diastolic changes in the left 
ventricle. 
 
Echocardiography is routinely used in daily practice, but the diagnostic value of this tool can 
be enhanced if proper analyses of the systolic as well as the diastolic profiles are determined. 
Many cardiologists only measure the systolic function of the heart as an indication of the 
well- being of the left ventricle, although in this study it was proven that systolic function did 
not alter with ageing or with changes in the risk profile. 
 
Hundred-and-twelve patients, divided into three age groups, were evaluated in this study. 
Both systolic and diastolic variables were measured and analysed for abnormalities. None of 
these patients had systolic function abnormalities, although they had detectable anatomic 
changes due to ageing, obesity and hypertension. Several abnormalities were found on the 
diastolic profile of these patients.  
 
 Muscle thickness increased due to obesity and hypertension and even with ageing, but with 
no significant abnormalities in the systolic function of the heart. There was a slight increase 
in the circumferential shortening of the left ventricle and that both the septal and longitudinal 
functions decreased with ageing. It is noteworthy that even where the systolic function 
remained normal in ageing subjects, their diastolic profiles changed significantly. 
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Assessment of left ventricular function required a meticulous and systematic approach.   In 
this study forty- one percent of patients visiting this general practice had abnormalities of 
their diastolic function although their systolic function was normal. It was found that with 
ageing, especially in the older age group, important abnormalities occur in their diastolic 
profile. The most common changes were that the E- peak velocity decreased and that the A- 
peak velocity of the trans-mitral flow increased. It seemed that passive filling decreased with 
ageing but that active filling increased simultaneously, causing the cardiac output to remain 
constant in older subjects. This is important to know because diseases affecting the atrium 
may have a profound effect on the cardiac output of older patients, even if they have normal 
systolic function, (due to the decreased passive filling they need their active filling or atrial 
contraction to support a normal cardiac output). An important marker will be to look at the 
ratio of the E/A- velocities in older patients to determine the ratio of active against passive 
filling. 
 
Other than that, a relatively new tool in echocardiography called tissue Doppler was used to 
determine what happened to the muscle with ageing. Here it was demonstrated that the 
different layers of the left ventricle acted differently with ageing. Results showed that the 
longitudinal fibres weakened with ageing although the circumferential fibres remained 
unchanged or even strengthened with ageing. 
 
It was apparent in this study that the traditional use of only systolic function may not be 
adequate when evaluating relative asymptomatic patients presenting at a general cardiology 
practice. It is important to also evaluate the diastolic profiles of these patients in order to 
scientifically quantify their heart health, even in asymptomatic patients. It is important to 
routinely evaluate the diastolic profile of patients so that early detection of these diastolic 
variables can be detected and timely consideration for its treatment can be given by their 
cardiologist. It is also important to take note of the significance of the obesity problem and 
the effect it has on the heart’s health. 
 
In conclusion, this study emphasizes the importance of the echocardiographic evaluation of 
diastolic cardiac function in addition to routine systolic evaluation in asymptomatic patients. 
This will enable the clinician to detect abnormalities early and tailor therapy accordingly. 
Lifestyle related risk factors, especially obesity, also have significant effects on diastolic 
cardiac function. 
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Opsomming 
 
Die hoofdoel van hierdie studie was om pasiënte in ŉ algemene kardiologiepraktyk te 
assesseer ten einde die sistoliese en diastoliese profiele van hierdie pasiënte te bepaal. Die 
doel was ook om te bepaal watter uitwerking leefstyl en risikofaktore mag hê op die eggo-
kardiografiese veranderlikes wat tydens so ŉ ondersoek gemeet word. Die spesifieke 
oogmerk van hierdie studie was die belangrikheid daarvan om nie alleen die sistoliese funksie 
te ondersoek nie, maar die noodsaak om ook die diastoliese profiel van pasiënte te ondersoek. 
Leefstyl speel ŉ belangrike rol, met obesiteit as die vernaamste sondebok. Obesiteit was die 
enkel belangrikste faktor wat die diastoliese profiel beïnvloed het van pasiënte wat in hierdie 
studie ondersoek is. Tesame met obesiteit is ŉ kombinasie van ander risikofaktore verwant 
aan obesiteit waargeneem. Die meeste abnormaliteite wat as gevolg van hierdie risikofaktore 
aangetref is, is geassosieer met diastoliese veranderinge in die linkerventrikel.  
 
Eggo-kardiografie word roetinegewys in die daaglikse praktyk gebruik, maar die diagnostiese 
waarde van hierdie hulpmiddel kan verhoog word indien behoorlike analises van die 
sistoliese sowel as die diastoliese profiele gemaak word. Talle praktyke meet slegs die 
sistoliese funksie van die hart as aanduider van die welstand van die linkerventrikel, alhoewel 
dit in hierdie studie bewys is dat sistoliese funksie nie verander met veroudering of met 
veranderinge in die risikoprofiel nie. 
 
Honderd-en-twaalf pasiënte, in drie ouderdomsgroepe ingedeel, is in hierdie studie 
geëvalueer. Sowel die sistoliese as die diastoliese veranderlikes is bepaal en geanaliseer vir 
abnormaliteite. Geeneen van hierdie pasiënte het abnormaliteite rakende sistoliese funksie 
getoon nie, alhoewel hulle sigbare anatomiese veranderinge as gevolg van veroudering, 
obesiteit en hipertensie getoon het. Talle abnormaliteite is aangetref op die diastoliese profiel 
van hierdie pasiënte.  
 
Spierdikte het toegeneem as gevolg van obesiteit en hipertensie en selfs met veroudering, 
maar met geen betekenisvolle abnormaliteite in die sistoliese funksie van die hart nie. Dit het 
getoon dat daar ŉ effense toename in die omtrek verkorting van die linkerventrikel was en dat 
beide die septale en lengte funksies afgeneem het met veroudering. Dit is belangrik om te 
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besef dat, selfs waar die sistoliese funksie normaal gebly het by ouer persone, hulle 
diastoliese profiele betekenisvol verander het. 
 
Die assessering van linkerventrikulêre funksie vereis ŉ noukeurige en sistematiese 
benadering.   In hierdie studie het een-en-veertig persent van die pasiënte wat hierdie 
algemene praktyk besoek het, abnormaliteite in hulle diastoliese funksie getoon, alhoewel 
hulle sistoliese funksie normaal was. Daar is bevind dat, met veroudering, veral in die ouer 
ouderdomsgroep, belangrike abnormaliteite in hulle diastoliese profiel voorkom. Die mees 
algemene veranderinge was dat die E-pieksnelheid afgeneem het en die A-pieksnelheid van 
die transmitrale vloei toegeneem het. Dit lyk asof passiewe vulling afneem met ŉ toename in 
ouderdom, maar dat aktiewe vulling tegelykertyd toeneem, wat veroorsaak dat die kardiale 
uitset dieselfde by ouer persone bly. Dit is belangrik om te weet, omdat siektes wat die atrium 
aantas ŉ groot invloed op die kardiale uitset van ouer pasiënte sal hê as gevolg van die 
verminderde passiewe vulling, dus verloor hulle hul aktiewe vulling of atriale kontraksie wat 
benodig word  om ŉ normale kardiale uitset te ondersteun. ŉ Belangrike merker sal wees om 
na die ratio van die E/A-snelhede by ouer pasiënte te kyk om die ratio van aktiewe teenoor 
passiewe vulling te bepaal. 
 
Hierbenewens is ŉ relatiewe nuwe hulpmiddel in eggo-kardiografie, genaamd weefsel-
Doppler, gebruik om te bepaal wat by veroudering met die spier gebeur. Hierdeur is 
aangetoon dat die verskillende lae van die linkerventrikel anders optree by veroudering. 
Resultate het aangetoon dat die lengteweefsel verswak met ouderdom, alhoewel die 
omtrekweefsel onveranderd bly, of selfs sterker word met veroudering. 
 
Dit was duidelik uit hierdie studie dat die tradisionele gebruik van slegs die sistoliese funksie 
nie toereikend is wanneer kardiologiepasiënte geëvalueer word nie. Dit is van die uiterste 
belang om ook die diastoliese profiele van hierdie pasiënte te evalueer ten einde op 
wetenskaplike wyse hulle hartgesondheid te verreken, selfs by asimptomatiese pasiënte. Dit 
is belangrik om roetinegewys die diastoliese profiel van pasiënte te evalueer sodat vroeë 
opsporing van hierdie diastoliese veranderlikes kan plaasvind en tydige oorweging vir die 
behandeling daarvan deur hulle kardioloog geskenk word. Dit is ook belangrik om kennis te 
neem van die belangrikheid van die probleme rakende obesiteit en die uitwerking wat dit op 
die hart se gesondheid het. 
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Ten slotte beklemtoon hierdie studie die belangrikheid van die eggo-kardiografiese 
evaluering van die diastoliese kardiale funksie bo en behalwe die roetine sistoliese evaluasie 
by asimptomatiese pasiënte. 
 
Dit sal die klinikus in staat stel om vroegtydig abnormaliteite op te spoor en 
dienooreenkomstig terapie toe te pas. Veranderinge in leefstyl, veral wat obesiteit betref, het 
ook ŉ betekenisvolle uitwerking op diastoliese kardiale funksie. 
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Chapter 1 
Introduction 
 
In the past decade it has become apparent that symptoms and prognoses of patients with 
congestive cardiac failure depend not only on left ventricular systolic function but also on left 
ventricular diastolic function (Pinamonti et al., 1993; Xie et al., 1994; Xie et al., 1996). 
 
Two-dimensional echocardiography and M-Mode is well suited for studies of left ventricular 
function, and Doppler echocardiography provides a non-invasive tool for the assessment of 
left ventricular diastolic function. Diastolic function of the left ventricle has been derived 
from flow velocities across the mitral valve. However, these measurements were influenced 
by load and age dependence, location of Doppler sample volume, rhythm and heart rate 
(Choong et al., 1987; Downes et al., 1990; Hurrell et al., 1997; Mantero et al., 1998; 
Nishimura et al., 1989; Nishimura et al., 1990; Stoddard et al., 1989; Sztajzel et al., 1993; 
Triulzi et al., 1990). 
 
Even though systolic and diastolic dysfunction often coexist, only a few Doppler 
echocardiographic variables combine measurements from systole and from diastole, but 
recently a new Doppler index of combined diastolic and systolic performance has been 
proposed (Tei et al., 1995). The Tei index has proven to be a reliable method for the 
evaluation of global left ventricular performance, with clear advantages over older 
established indexes and prognostic value in many kinds of heart disease (Lakoumentas et al., 
2004). 
 
It might be valuable to combine all these parameters in an echocardiographic study and use it 
in the decision-making process when treating patients. This study attempted to evaluate the 
changes in Doppler profiles during normal follow up of patients in a cardiology practice. 
Demographic data were taken into consideration as well as known disease processes and risk 
factors that can have an effect on these measurements.  
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This study is based on the hypothesis that routine Doppler systolic and diastolic evaluation is 
important even in asymptomatic patients and that routine evaluation of Doppler parameters 
should be considered during evaluation of patients at follow-up.   
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Chapter 2 
Literature review 
 
2.1   Introduction 
 
The cardiovascular fetal system is the first system to reach a functional state in human 
development at age five weeks. The primitive heart is a tubular structure, which forms like a 
large blood vessel from mesenchymal cells in a region of embryonic tissue called the 
“cardiogenic area”. The primitive heart tube is formed by the fusion of two thin-walled 
endocardial heart tubes and is located in the floor of the future pericardial cavity. The 
splanchnic mesenchyme adjacent to this tubular heart then condenses, forming the primordial 
myocardium and epicardium (Moore et al., 1988). 
 
The heart is composed of three major types of cardiac muscle: atrial muscle, ventricular 
muscle, and specialised excitatory and conductive muscle fibres. The atrial and ventricular 
types of muscle contract in much the same way as skeletal muscle, except that the duration of 
contraction is much longer. On the other hand, the specialised excitatory and conductive 
fibres contract only feebly because they contain few contractile fibrils; instead, they exhibit 
rhythmicity and varying rates of conduction, providing an excitationary system of the heart 
(Guyton et al., 1996). 
 
The term “excitation-contraction coupling” indicates the mechanism by which the action 
potential causes the myofibrils of muscle to contract (Guyton et al., 1996). When an action 
potential passes over the cardiac muscle membrane, the action potential also spreads to the 
anterior of the cardiac muscle fibre, along the membranes of the transverse (T) tubules. The 
T- tubule action potential in turn acts on the membranes of the longitudinal sarcoplasmic 
tubules to cause instantaneous release of calcium ions into the muscle sarcoplasm from the 
sarcoplasmic reticulum. In another few thousands of a second, these  calcium ions diffuse 
into the myofibrils and catalyse the chemical reaction that promote sliding of the actin and 
myosin filaments along one another; this in turn produces the muscle contraction (Guyton et 
al., 1996). 
Any factor that increases venous return or slows the heart produces greater ventricular filling 
(preload) during the cardiac cycle’s diastolic phase. An increase in end-diastolic volume 
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stretches myocardial fibres and initiates a powerful ejection stroke during contraction. This 
ejects the normal stroke volume plus any additional blood that entered the ventricles and 
stretched the myocardium (Mc Ardle et al., 2001). Two researchers, German physiologist 
Otto Frank (1865-1944) and British physiologist Ernest Starling (1866-1927) described the 
relationship between contractile force and the resting length of the heart’s muscle fibres. This 
phenomenon, Starling’s law of the heart, always operates during the cardiac cycle and applies 
to all of the heart’s chambers (Mc-Ardle et al., 2001). This is termed cardiac systole.  
Doppler changes in cardiac systole and diastole are what this study aims to investigate. 
 
2.2        Echocardiography 
2.2.1 Introduction 
 
Since Doppler’s inception as a tool in clinical cardiology, echocardiography has been used to 
assess left ventricular systolic function. Doppler methodology determining intracardiac blood 
flow and tissue motion has evolved into a valuable technique for assessing the diastolic 
function (Feigenbaum et al., 2005). 
 
Evaluation of ventricular systolic function is the most important application of 
echocardiography, so that even when evaluation of systolic function is not the focus of the 
examination, it plays an essential role in every study (Otto, 2004).  
 
Assessment of systolic and/or diastolic function provides valuable prognostic information. In 
nearly all instances, an assessment of left ventricular systolic function should be an integral 
part of the routine examination (Feigenbaum et al., 2005). Both systolic and diastolic 
functions change as a disease processes, regresses or progresses. The treatment strategy for a 
patient’s condition is affected by systolic and diastolic functions. Hence, echocardiography is 
especially useful for monitoring serial changes in systolic and diastolic functions in response 
to treatment and for following the progression of a patient’s underlying cardiovascular 
disease (Oh et al., 1999).   
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2.2.2 Systolic function as part of the cardiac cycle 
 
Systole typically is defined as the segment of the cardiac cycle from mitral valve closure to 
aortic valve closure. The onset of systole is defined by the electrocardiogram as ventricular 
depolarisation (onset of the QRS complex), with the end of systole occurring after 
repolarisation (end of T-wave). In terms of ventricular pressure and volume curves over time, 
systole begins when left ventricular diastolic pressure exceeds left atrial pressure, resulting in 
closure of the mitral valve (Otto, 2004). 
 
 
 
 
Fig 2.1       The cardiac cycle 
                  (Adapted and modified from Nichols et al., 1998) 
 
Mitral valve closure is followed by isovolumic contraction, during which the cardiac muscle 
depolarises, calcium influx and myosin-actin shortening occur, and ventricular pressure 
increases rapidly at a constant ventricular volume. When ventricular pressure exceeds aortic 
pressure, the aortic valve opens. During ejection, left ventricular volume falls rapidly as 
blood flows from the left ventricle to the aorta (See Fig 2.1). 
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“Systolic function” is affected by ventricular preload, ventricular afterload, intrinsic 
ventricular contractility, and heart rate. Asynchronous ventricular contraction secondary to 
coronary artery disease or a ventricular pacemaker may also affect systolic function. 
 
Fundamentally, ventricular systolic function is best described by contractility: the ability of 
the myocardium to contract. However, contractility is affected by several physiologic 
parameters including, heart rate, coupling interval, metabolic factors and pharmacologic 
agents. In addition, for a given degree of contractility ventricular ejection performance can 
vary depending on preload and afterload (Otto, 2004). 
 
Quantification of cardiac chamber size, ventricular mass, and function ranks among the 
clinically most important and most frequently requested tasks of echocardiography. 
Standardisation of chamber quantification has been an early concern in echocardiography and 
recommendations on how to measure such fundamental parameters are among the most 
frequently cited articles in the field (Sahn et al., 1978; Schiller et al., 1989). 
 
According to Oh et al. (1999), the three variables used most frequently to express left 
ventricular global systolic function are: 
 
A.  Fractional shortening. 
B.  Ejection fraction. 
C.  Cardiac output.  
 
Otto (2004) concluded that there are several other imaging parameters that provide a 
qualitative measurement of left ventricular systolic function, namely  
M-Mode measurements: 
 The separation between the maximum anterior motion of the mitral leaflet and the 
maximum posterior motion of the ventricular septum (E- point septal separation). 
 The degree of anteroposterior motion of the aortic root.  
 
Qualitative evaluation of overall systolic function is a simple and highly predictive index that 
is of great clinical utility e.g. pre-surgery evaluation. However, several factors can limit the 
usefulness of this evaluation (Otto, 2004). Ejection fraction is a global index of systolic 
function and one of the most commonly used markers of systolic function (Kerut et al., 
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2004). This simple measurement has been found to be a strong predictor of clinical outcome 
in almost all major cardiac conditions and is used to select the optimal management strategy, 
including the implantation of intracardiac defibrillator or biventricular pacing (Otto, 2004). 
 
The most commonly used assessment of left ventricular systolic function is the ejection 
fraction (Feigenbaum et al., 2005; Roldan, 2005). The reason for this is that it is easy to do, it 
can be repeated regularly and is cost effective. 
 
2.3        Fractional shortening 
 
Fractional shortening can be described as the percentage change in the dimension of the left 
ventricle that occurs during systolic contraction (Oh et al., 1999). 
 
It is a commonly used M-mode index of systolic performance and if no segmental left 
ventricle wall motion abnormalities are present, the fractional shortening and ejection fraction 
correlate well (Kerut et al., 2004). 
Fractional shortening can be seen as a rough measurement of left ventricular systolic function 
(Otto, 2004) and alterations in preload and afterload can alter fractional shortening (Roldan, 
2005). 
 
Kerut  et al. (2004) defined fractional shortening (FS) as follows: 
FS% = 100 [(LVEDD)-(LVESD)]/ (LVEDD) 
Where LVEDD is the left ventricle end-diastolic dimension and LVESD is left ventricle end-
systolic dimension. 
 
According to Otto (2004), the normal range is 25% to 45% (95% confidence limits). 
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2.4          Ejection fraction 
 
Ejection fraction can be used as the global index of systolic function and one of the most 
commonly used markers of systolic function (Feigenbaum et al., 2005; Kerut et al., 2004; 
Roldan, 2005). 
 
According to Kerut et al. (2004), the ejection fraction (EF) is the stroke volume (SV) divided 
by the end-diastolic volume (EDV): 
 
EF = (SV/EDV) 100% 
 
And since   SV = (EDV-ESV) where ESV = end-systolic volume, 
 
Therefore EF = [(EDV-ESV)/EDV] 100%. 
 
According to Kerut and co-workers (2004), errors in estimating the ejection fraction may 
result from: 
 Underestimation of ejection fraction because of endocardial echo dropout and the 
eyeball seeing mostly epicardial motion;     
 Underestimation of ejection fraction when the left ventricle cavity is significantly 
enlarged. A large left ventricle can eject a large volume with less endocardial motion; 
 Overestimation of ejection fraction in a normal left ventricle; and/or 
 Significant left ventricle regional wall motion abnormalities. 
 
Kerut et al. (2004) also concluded that quantitative methods to calculate ejection fraction are 
usually preferable. Left ventricle volume is obtained and from this the ejection fraction 
calculated. For an accurate ejection fraction calculation, one must be able to obtain proper 
positioned images along with good endocardial visualisation. 
 
Otto (2004) stated that the following factors that can limit the usefulness of systolic function 
with ejection fraction measurement are: 
 
 Firstly, the accuracy of the estimated ejection fraction is dependent on the 
experience of each observer. 
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 Secondly, inadequate endocardial definition can result in incorrect estimates of 
systolic function. 
 Thirdly, integration of data from multiple tomographic images can be difficult 
when the pattern of contraction is asynchronous (with conduction defects, 
pacers, postoperative septal motion) or when the pattern of contraction is 
asymmetric (with prior myocardial infarction or with ischemia), especially 
when dyskinesis is present (See Fig 2.2). 
 
 
Fig 2.2  Schematic representation of a parasternal long axis view of the left      
ventricle. 
                 (Adapted from Feigenbaum et al., 2005).             
 
2.5      Cardiac output 
 
Cardiac output provides the most significant indicator of the circulatory system’s functional 
capacity to meet the demands for physical activity. As with any pump, the rate of pumping 
(heart rate) and quantity of blood ejected with each stroke (stroke volume) determine the 
heart’s output of blood (McArdle et al., 2000). McArdle et al. (2000) also concluded that 
blood flow from the heart increases in direct proportion to exercise intensity. From rest to 
steady-rate exercise, cardiac output increases rapidly, followed by a more gradual increase 
until it plateaus as blood flow matches exercise metabolic requirements. In sedentary, 
college-age men, cardiac output in strenuous exercise increases about four times the resting 
level to an average maximum of 22 l/min. Maximum heart rate for these young adults 
averages 195 b/min. Consequently, stroke volume averages 113 ml of blood per beat during 
maximal exercise (22 000 ml ÷ 195). In contrast, world-class endurance athletes generate 
maximum cardiac output of 35 l/min, with a similar or slightly lower maximum heart rate 
than untrained counterparts (McArdle et al., 2000). The difference between maximum cardiac 
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outputs of aforementioned individuals relates solely to differences in stroke volume. The 
cardiac output of the Nordic Olympic medal winner in cross-country skiing increased eight 
times above rest to 40 l/min during a maximum exercise test. The accompanying stroke 
volume averaged 210 ml per beat, twice the volume of blood pumped per beat compared to 
the maximum stroke volume of a healthy, sedentary person of the same age (McArdle et al., 
2000). 
 
Otto (2004) concluded that the basic function of the heart is as a pump, so that measurements 
of cardiac output may thus be useful in routine day-to-day patient treatment. Cardiac output is 
the volume of blood pumped by the heart per minute, with stroke volume being the amount 
pumped during a single beat. While cardiac output can be derived from ventricular volumes 
as described above, a variety of other approaches to measurement are available, including 
indicator dilation methods (Fick, thermo-dilution), Doppler-velocity data, ventricular 
impedance, and radio nuclide methods. 
 
Ventricular systolic function and cardiac output are dynamic, responding rapidly to the 
metabolic demands of the individual. Cardiac output increases from a mean of 6 l/min at rest 
to 18 l/min with exercise in young, healthy adults. Most of this increase in cardiac output is 
mediated by an increase of heart rate (McArdle et al., 2000). 
 
With supine exercise there is only a minimal increase in stroke volume of approximately 
10%, where as with upright exercise, the increase in stroke volume is approximately 20%- 
35%. With exercise, end-diastolic volume is unchanged or slightly decreased, but ejection 
fraction increases and end-systolic volume decreases (Otto, 2004). According to McArdle et 
al. (2000), two physiologic mechanisms regulate stroke volume and contribute in varying 
degrees to stroke volume increases during exercise.  
 
The first mechanism, intrinsic to the myocardium, requires greater diastolic filling followed 
by a forceful systolic ejection. The second, governed by neurohormonal influences, involves 
normal ventricular filling followed by a forceful systolic ejection to cause systolic emptying 
(McArdle et al., 2000). 
 
McArdle and co-workers (2000) found that greater ventricular filling during diastole in the 
cardiac cycle occurs due to any factor that increases venous return (preload), or slows heart 
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rate. An increase in end-diastolic volume stretches myocardial fibres, causing a powerful 
ejection stroke as the heart contracts. This expels the normal stroke volume plus the 
additional blood that entered the ventricles and stretched myocardium. The German 
physiologist Frank Otto (1865-1944) and a British colleague Ernest H. Starling (1886-1927) 
who experimented with animals in the early 1900s first described relationships between 
muscle force and the resting fibre length. Improved contractility of a stretched muscle (within 
a limited range) relates to a more optimum arrangement of intracellular myofilaments as the 
muscle stretches. Frank-Starling’s law of the heart describes this phenomenon applied to the 
myocardium (McArdle et al., 2000). 
 
McArdle et al. (2000) also concluded that physiologists taught the Frank-Starling mechanism 
as the “modus operandi” for all increases in stroke volume during exercise. They believed 
that enhanced venous return in exercise caused greater cardiac filling which in turn stretched 
the ventricles in diastole to produce a more forceful ejection. In all likelihood, this pattern 
describes the stroke volume response in transition from rest to exercise, or when a person 
moves from the upright to recumbent position. Enhanced diastolic filling probably also 
occurs in activities like swimming, in which the body’s horizontal position optimises venous 
return and myocardial preload (McArdle et al., 2000). 
 
Cardiac output and stroke volume reach the highest and most stable levels in the horizontal 
position. Near-maximal stroke volume occurs at rest in the horizontal position and increases 
only slightly during exercise. This postural effect becomes prominent when comparing 
circulatory dynamics at rest in the upright and supine positions. As upright exercise intensity 
increases, stroke volume also increases to approach the maximum value in the supine position 
McArdle et al. (2000). 
 
In most forms of upright exercise, the heart does not fill to an extent that significantly 
increases cardiac volume to values observed in the recumbent position. The increase in stroke 
volume during exercise likely results from the combined effects of enhanced diastolic filling 
and more complete systolic emptying. In both recumbent and upright position, the heart’s 
stroke volume increases in exercise despite resistance to flow-increased systolic pressure 
(afterload), McArdle et al. (2000). 
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At rest in the upright position, 40% to 50% of the total end-diastolic blood volume remains in 
the left ventricle after systole; this residual volume of the heart amounts to 50-70 ml of blood. 
The sympathetic hormones epinephrine and norepinephrine enhance myocardial stroke power 
and systolic emptying during exercise, which reduces the heart’s residual volume. The time 
velocity integral (TVI), also called velocity time integral, is the area measured under the 
Doppler velocity envelope for one heartbeat.  From the TVI the stroke volume (SV), and 
hence cardiac output (CO) and cardiac index (CI) may be calculated. The area (A) is obtained 
at the same level as the TVI measurement was made (Kerut et al., 2004). Left ventricular SV 
may be calculated as follows: 
 
SV = TVIOT X AOT 
 
SV = TVIOT X [D/2]² X π  
 
SV = TVIOT X D² X 0.785 
 
Where D is the left ventricle outflow tract (LVOT) diameter in centimetres, TVIOT is the TVI 
of the LVOT in centimeters, and AOT is the calculated area of the LVOT. Kerut et al. (2004) 
also concluded that TVI and area measurement can be made at many sites, including the 
ascending aorta, aortic annulus, mitral inflow, tricuspid inflow, and pulmonary valve levels.  
 
The aortic annulus is the most accurate of all the valves for stroke volume measurements. The 
aortic diameter is measured in the parasternal long axis in early mid systole, and the pulsed 
wave Doppler of aortic TVI obtained from the apical five-chamber view. The pulsed wave 
(PW) sample is placed at the same level as where the diameter measurement was made. SV 
measurement at the level of the tricuspid valve (TV) is generally not very accurate Kerut et 
al. (2004).  
According to Kerut and co-workers (2004) this method of stoke volume determination makes 
the assumption that: 
 The velocity profile is flat. 
 The area of the profile is constant during the time obtaining the TVI. 
 Flow is laminar (not turbulent). 
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2.6      Cardiac mass and index 
 
Echocardiography was one of the first imaging modalities used clinically for determination of 
left ventricular mass. It has received widespread acceptance in epidemiologic studies of 
hypertension and valvular heart disease in which the presence of hypertrophy has been 
associated with worsened outcomes and its regression has been a goal of therapy 
(Feigenbaum et al., 2005). Left ventricular mass can be determined using a number of 
echocardiographic formulas and algorithms and has been shown to carry substantial 
prognostic importance in virtually all forms of heart disease.  
 
Left ventricular mass can be estimated from M-mode dimensions of septal thickness (ST), 
posterior wall thickness (PWT), and the left ventricular internal dimension (LVID) at end-
diastole. Note that the original description of this method by Reichek and Devereux used 
PENN convention measurements with the endocardial echoes included in wall thickness and 
excluded from chamber dimensions (rather than leading edge to leading edge) (Otto, 2004). 
 
According to Feigenbaum et al. (2004) the earliest methodology for determining ventricular 
mass was based on M-mode measurement of septal and posterior wall thickness and the left 
ventricular internal dimension. M-mode calculation assumes a predefined ventricular 
geometry, and their accuracy will diminish in instances in which the left ventricular shape is 
abnormal. 
 
One of the methods for determining left ventricular mass is the so-called cubed (Teicholtz) 
formula, which assumes that the left ventricle is a sphere. The diameter of this sphere is the 
interior dimension of the left ventricle and the sphere wall thickness is that of ventricular 
myocardium. The formula calculates the outer dimension of the sphere and then the inner 
dimension, the difference being the presumed left ventricular myocardial volume 
(Feigenbaum et al., 2005). 
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Fig. 2.3   Methods for determining left ventricular mass using two-dimensional                                          
.                        measurements 
              (Adapted from Schiller et al., 1989.) 
 
The cubed formula is expressed as left ventricular mass = (interventricular septum + left 
ventricular interior dimension + posterior wall)³ - left ventricular interior dimension³ 
(Feigenbaum et al., 2004). The cubed methodology (Fig. 2.3) has been widely used, 
especially in serial evaluations, because for any given patient, the magnitude and direction of 
the error would be expected to remain constant and therefore the technique could be used for 
evaluating serial changes. A more accurate determination of left ventricular mass can be 
obtained with two-dimensional echocardiography. 
 
When using two-dimensional echocardiography, geometric assumptions of the ventricular 
shape are typically still employed but the assumption is that of a bullet-shaped ventricle 
rather than a sphere (Feigenbaum et al., 2004). 
 
Additionally, mean left ventricular wall thickness is determined rather than wall thickness at 
only one point on the septum and posterior wall. Mean wall thickness can be calculated by 
determining the epicardial and endocardial areas of the short axis of the left ventricle at the 
mid-cavity level. The difference between these two areas then represents the myocardial area. 
The left ventricular area can then be calculated either by an area length method or by 
assuming a truncated ellipse geometry (Feigenbaum et al., 2004). 
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According to Kerut et al. (2004), M-mode echocardiography has been used for LV mass and 
volume calculations. LV-mass quantification using M-mode is based on the assumption that 
the LV is a prolate ellipsoid with a 2:1 long/short axis ratio. This assumption is fairly 
accurate for normally shaped ventricles, but for patients with LV segmental wall motion 
abnormalities or valvular regurgitation with altered LV geometry, this may not be accurate. 
 
The well-validated cube formula for LV mass calculations using M-mode echo is: 
 
LV mass = 0.8{1.04[(IVS+LVID+PWT)³-LVID³]}+0.6g 
 
Where (ASE guidelines for measurements) IVS is diastolic interventricular septal thickness, 
LVID is diastolic LV internal dimension and PWT is diastolic posterior left ventricular wall 
thickness. 
 
The PENN convention has also well described LV mass by another form of the cube formula: 
 
LV mass = 1.04[(IVS+LVID+PWT)³-(LVID)³]-13.6g 
 
Kerut and co-workers (2004) concluded when using this formula that normal mass values for 
males are 93±22g/m² and for females 76±18g/m². 
Left ventricle volumes using M-mode, may be made using cube formula (V=LVID³), but 
dilated ventricles will have an overestimated volume. 
The Teichholz equation gives the best M-mode formula for estimating LV volume: 
 
Vdiastole = [7/ (2.4 +LVID)][LVID³] 
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2.7             Diastolic dysfunction 
2.7.1  Introduction  
 
It has become widely recognised that virtually all forms of acquired organic heart disease are 
associated with a component of left ventricular diastolic dysfunction (Feigenbaum et al., 
2005). 
 
There has been increasing recognition that diastolic ventricular function often plays an 
essential role in the clinical manifestation of disease in patients with a wide range of cardiac 
disorders. For example, many patients with clinical heart failure have normal systolic 
function with predominant diastolic dysfunction. Diastolic dysfunction may be an early sign 
of cardiac disease, often preceding clinical or echocardiographic evidence of systolic 
dysfunction (Otto, 2004). 
 
Abnormalities of diastolic filling are increasingly recognised to play an important role in the 
symptomatology and prognosis of many forms of heart disease. It is well known that left 
ventricular diastolic dysfunction usually precedes systolic dysfunction and abnormal 
relaxation is observed at an early stage (Dougherty et al., 1984; Grossman et al., 1976; Ishida 
et al., 1986).  
 
Diastolic dysfunction with preserved ejection fraction accounts for 40% to 50% of heart 
failure cases in population-based studies. This observation has stimulated increased interest in 
the ability to characterize diastolic function non-invasively. The natural history of diastolic 
dysfunction is characterised by an initial and progressive impairment in the left ventricular 
relaxation followed by a superimposed decline in left ventricular compliance that results in 
the need for increased atrial pressures to maintain left ventricle filling and cardiac output. 
 
 
 
 
 
 
 
S t e y n  P a g e  | 17 
 
2.7.2 Diastolic properties of the left ventricle  
 
Diastole of the cardiac cycle has traditionally been divided into 4 phases: isovolemic 
relaxation, early rapid filling, diastases and atrial contraction. 
 
The isovolumic relaxation time is a continuum of the systolic cardiac cycle and is, dependent 
on systolic function in addition to relaxation of the left ventricle.  The early diastolic filling 
phase is dependent on both left ventricle relaxation and chamber compliance. The slow 
diastolic filling phase, or diastases, is dependent on heart rate and chamber compliance. The 
atrial contraction phase is dependent on the chamber compliance, left atrial function, and the 
electrical conduction system of the heart (Khouri et al., 2004). 
 
In addition to the 2 major determinants of diastolic function (ventricular relaxation and 
compliance), there are numerous independent factors that affect left ventricle properties and 
the filling of the left ventricle. Ventricular relaxation is a complex energy-dependant process 
during which the contractile elements are deactivated and the myofibrils returned to their 
original length. In other words, ventricular relaxation can be thought of as the duration of the 
decrease in left ventricle pressure after systolic contraction (Khouri et al., 2004). 
 
According to Otto (2004), there are several physiologic parameters that can be used to 
describe different aspects of diastolic function, but there is no single measure of overall 
diastolic function. The most clinically relevant parameters of diastolic function are: 
 
 Ventricular relaxation; 
 Myocardial or chamber compliance; and  
 Filling pressures. 
 
Additional parameters of interest include elastic recoil of the ventricle and the effect of 
pericardial constraint, but the importance of these factors in normal diastolic ventricular 
function remains controversial. 
 
Assessment of left ventricle diastolic function requires a meticulous and systematic approach. 
The initial evaluation begins with echocardiographic observation of standard M-mode and 2-
dimensional anatomic imaging. Anatomic evaluation of left atrium diameter and volume, left 
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ventricle mass, left ventricle relative wall thickness, and left ventricle systolic function should 
be the first step in the evaluation of diastolic dysfunction (Fig. 2.4) (Appleton et al., 1993 and 
2000). 
 
Although several different definitions of diastole have been proposed, the most widely 
accepted clinical definition is the interval from aortic valve closure (end-systole) to mitral 
valve closure (end-diastole). The isovolumic contraction period, from mitral valve closure to 
aortic valve opening, typically is considered as part of systole (Otto, 2004).  
Diastole can be divided into four phases: 
 Isovolumic relaxation  
 The early rapid filling phase  
 Diastasis  
 Late diastolic filling due to atrial contraction. 
 
 
Fig. 2.4 “Diastolic filling of left ventricle. Schematic representation of left ventricle, left atrial, and 
ascending aorta pressure. Cardiac cycle is classically divided into systole and 4 phases of 
diastole: isovolumetic relaxation, rapid filling, slow filling, and atrial contraction. Each phase 
is dependent on variables shown above. In a more practical and simplified system, cardiac 
cycle is divided into contraction, relaxation, and diastolic filling. Each of 3 phases is 
dependent on effects of preceding phase as shown above. Adapted with permission from The 
American College of Cardiology Foundation” (Adapted from Nishimura et al., 1997). 
 
It was not until the widespread availability of Doppler echocardiography that evaluation of 
diastolic function of the left ventricle became a viable clinical tool. There are a number of 
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Doppler approaches for determining diastolic function, including determination of mitral 
inflow patterns with pulsed Doppler imaging, evaluation of pulmonary vein flow, and the 
newer technique of tissue Doppler imaging (TDI), which can be used as a stand-alone 
technique or combined with mitral inflow patterns. A word of caution is advised when using 
Doppler parameters as markers of diastolic dysfunction. The accuracy and validity of 
Doppler markers of diastolic function are greatest in the presence of systolic dysfunction, and 
individual parameters may lose their validity in the presence of normal systolic function 
(Feigenbaum et al., 2005).  
 
For evaluation of diastolic properties of the left ventricle, the mitral inflow pattern is 
evaluated from an apical transducer position with the sample volume placed at the tips of the 
mitral valve. Normal mitral inflow consists of biphasic flow from the left atrium into the left 
ventricle. In a healthy, disease-free individual, the early flow, coincident with the mitral  
E-wave, exceeds the later flow, which occurs with atrial systole both in velocity and volume. 
The magnitude of these flows, as well as their ratios, varies with age in the normal 
population. In healthy, young, disease-free individuals, the E-wave exceeds the A-wave, and 
therefore the E/A ratio is more than 1.0. In adolescents and young adults, there may be a 
disproportionate contribution of active ventricular relaxation to ventricular filling, which 
results in a markedly accentuated E-wave velocity. In this instance, the E/A ratio can exceed 
a value of 2.0 in a normal, disease-free individual. With advancing age, there is natural 
stiffening of the ventricle, which results in delayed relaxation. This results in a progressive 
decrease in E-wave velocity and an increase in  A-wave velocity with age so that the 
anticipated E/A ratio in a disease-free individual older than the age of 60 is often less than 
1.0. With pathologic degrees of stiffening of the left ventricular myocardium, a hierarchy of 
changes can be seen in the mitral inflow patterns (Feigenbaum et al., 2005). 
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2.8          Grading of diastolic dysfunction 
 
In most cardiac disease, the initial dysfunction is impaired relaxation (Fig. 2.5). 
 
 
Fig. 2.5       Echocardiographic classification of diastolic dysfunction.  
                             Adapted with permission from the American Medical Association. 
                             (Adapted  from Redfield et al., 2003.) 
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With further progression of the disease and a mild to moderate increase in LA pressure, the 
mitral inflow velocity pattern appears similar to a normal filling pattern (pseudo-normalised) 
(Oh et al., 2006). After following a further decrease in LV compliance and increase in LA 
pressure, the diastolic filling becomes restrictive. Most patients with restrictive filling are 
symptomatic and have a poor prognosis unless the restrictive filling can be reversed by 
treatment (Capomolla et al., 2001).  
 
Therefore, diastolic dysfunction can be graded as follows according to the diastolic filling 
pattern (Nishimura et al., 1997): 
Grade 1 = impaired relaxation pattern with normal filling pressure 
Grade 1a= impaired relaxation pattern with increased filling pressure 
Grade 2 = pseudo-normalised pattern  
Grade 3 = reversible restrictive pattern  
Grade 4 = irreversible restrictive pattern 
 
Fig. 2.6 “Grading of diastolic dysfunction from normal to severe dysfunction (grade 3-4), evaluated by 
Pulse Wave (PW) Doppler of mitral inflow. Normal: DT 140-240 msec; E/A 0.75-1.5. Grade 
1: DT> 220 msec, E/A <0.75. Grade 2: DT 140-220 msec, E/A 0.75-1.5. Grade 3-4: DT < 
140 msec, E/A > 1.5; in grade 3, the E/A ratio is reversible, when compared to grade 4, with 
the pre-load changes”. (Adopted from Scipione Carerj et al., 2009.) 
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2.8.1         Grade 1  
 
In nearly all types of cardiac disease, the initial abnormality of diastolic filling is slowed or 
impaired myocardial relaxation (Fig 2.5). The IVRT is prolonged. Mitral E velocity is 
decreased and A velocity increased, producing an E/A ratio less than 1 with prolonged DT 
(Fig 2.6). Whenever the E/A ratio is less than 1, impaired relaxation is usually present (Oh et 
al., 2006). E’(Passive myocardial relaxation) is also reduced, usually less than 7 cm/s (at the 
septal annulus).  
 
Diastolic filling pressure is not increased and the E/E’ is 8 or less (Ommen  et al., 2000). In a 
subgroup of patients, E/E’ is greater than 15, with E/A less than 1. This pattern has been 
designated grade 1a diastolic dysfunction in order to emphasise that the filling pressure is 
increased in the presence of a typical grade I mitral-inflow velocity pattern (Oh et al., 2006). 
The “classic” pattern of mild left ventricular diastolic dysfunction is seen with left ventricular 
hypertrophy due to hypertension or to valvular aortic stenosis. The predominant abnormality 
is impaired relaxation, resulting in a pattern of reduced early diastolic filling and an enhanced 
atrial contribution to filling.  
 
The Doppler velocity curve shows a prolonged IVRT, reduced acceleration to a reduced E 
velocity, prolonged early diastolic deceleration slope, an increased A velocity, and an E/A 
ratio <1. When left ventricular systolic dysfunction supervenes, the elevated left ventricular 
end-diastolic pressure and elevated left atrial pressure may result in “pseudo-normalisation” 
of this pattern with an enhanced E velocity and reduced A velocity. Coexisting mitral 
regurgitation also can lead to a “paradoxical” higher E velocity despite impaired ventricular 
relaxation (Otto, 2004). 
 
Increased left ventricular mass decreases the rate of myocardial relaxation. In most of the 
patients with left ventricle hypertrophy, diastolic filling velocities consist of decreased E 
velocity with prolonged DT, increased A velocity, and E/A ration of less than 1 (Douglas et 
al., 1989). As the myocardium becomes more fibrotic or stiff, the diastolic filling pattern 
evolves to a more pseudo-normal pattern and finally a restrictive ventricular filling can be 
seen in the setting of normal to hyperdynamic systolic function. However, in patients with 
hypertrophic cardiomyopathy, diastolic filling parameters appear to have a poorer correlation 
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with left ventricular pressure, most likely a result of more profound relaxation abnormalities 
in the presence of significant left ventricular hypertrophy (Symanski et al., 1995). 
2.8.2 Grade 2  
 
As diastolic function deteriorates, the mitral inflow pattern goes through a phase that 
resembles a normal diastolic filling pattern, that is, the E/A ratio is 1 to 1.5 and DT is normal 
at 160 to 220 milliseconds. This is the result of a moderately increased LA pressure 
superimposed on a relaxation abnormality (Fig. 2.6). The best way to identify a pseudo-
normalised pattern is to demonstrate impaired relaxation by E’ less than 7 cm/s and increased 
filling pressure by E/E’ greater than 15 (Oh et al., 2006). Afterload of the left ventricle is 
defined as the resistance to ejection of blood from the ventricle to the systemic circulation. In 
other words, afterload represents the systemic vascular resistance.  
 
Alteration of afterload can alter the diastolic profiles. Changes in afterload primarily affect 
the rate of left ventricular relaxation with subsequent changes in the transmitral inflow curve. 
An increase in afterload prolongs ventricular relaxation. Hence, the crossover of pressure 
between the left ventricle and left atrium occurs later. This results in a smaller initial driving 
pressure between the left ventricle and left atrium and a reduction in the peak mitral E wave 
velocity. Furthermore, there is also a decreased rate of fall in the gradient between the left 
atrium and left ventricle because of continued delayed myocardial relaxation, resulting in 
prolongation of the deceleration time. Finally, because there is less filling in early diastole, 
there will be greater filling with atrial contraction (increased A wave velocity). 
 
Note that an increase in afterload produces the same effect as a decrease in preload 
(Anderson, 2004). 
 
2.8.3 Grade 3 and 4   
 
The term restrictive diastolic filling, or restrictive physiology, should be distinguished from 
restrictive cardiomyopathy. The increase in LA pressure results in earlier opening of the 
mitral valve, shortened  IVRT, and an increase in early LV diastolic pressure, with rapid 
equalisation of the LV and LA pressures producing a shortened deceleration time DT. Atrial 
contraction increases LA pressure, but A velocity and duration are shortened because LV 
pressure increases even more rapidly.  Therefore, restrictive physiology is characterised by 
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mitral flow velocities that show increased E velocity, decreased A velocity and shortened DT 
(< 160 msec) and IVRT (< 70 msec). Typically, the E/A ratio is more than 2.0 and 
occasionally increases to 5 (Fig. 2.6). Because myocardial relaxation is impaired in patients 
with a restrictive filling pattern, mitral annulus E’ is reduced (< 7 cm/s and usually, < 5 
cm/s). 
 
The Valsalva manoeuvre may reverse a restrictive filling pattern to a grade 1 or 2 pattern, 
indicating the reversibility of high filling pressure (grade 3 diastolic filling). However, even if 
the restrictive filling pattern does not change with the Valsalva manoeuvres, reversibility 
cannot be adequate or filling pressure may be too high to be altered by the manoeuvres. 
Diastolic filling should be graded “irreversible restrictive” (grade 4) only when there is 
objective evidence of a persistent restrictive pattern with normal filling pressure (Oh et al., 
2006). 
 
2.9  Effects of age on diastolic function 
 
With ageing, there is a gradual decrease in the rate of myocardial relaxation and elastic recoil 
and, therefore, the left ventricle pressure declines and filling becomes slower. With a normal 
left atrial pressure, the pressure crossover between the left ventricle and left atrium occurs 
later and the early transmitral pressure gradient is decreased. Hence, the isovolumetric 
relaxation time (IVRT) becomes longer and the mitral E velocity decreases with increasing 
age. Furthermore, the reduced filling in early diastole retards the equilibrium between the left 
ventricle and left atrium, resulting in prolongation of the deceleration time. Because early 
filling of the left ventricle is reduced, the contribution from atrial contraction becomes 
significant. These result in a gradual increase in the mitral A-velocity with ageing. Pulmonary 
venous flow velocities show similar changes with ageing. Since the pulmonary venous flow 
in diastole parallels the early mitral inflow, it follows the mitral E velocity that decreases with 
age, and consequently the pulmonary venous D velocity also decreases with advancing age. 
To compensate for this reduction in diastolic filling, systolic forward flow becomes more 
prominent. Note that the mitral inflow and pulmonary venous flow profiles in young 
individuals may be similar to that of the restrictive filling pattern. In these individuals, the 
mechanism producing this filling pattern is vigorous, normal relaxation rather than the high-
driving pressure that occurs with restrictive physiology. Furthermore, the pulmonary venous 
D velocity may be greater than the pulmonary venous S velocity in normal young persons. In 
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addition, there may also be shortening of the mitral A-wave duration. However, when 
compared to the pulmonary venous atrial reversal duration, the mitral A-wave duration 
should be equal to or slightly longer than the pulmonary venous atrial reversal wave. In 
patients with restrictive physiology the reverse is true (the mitral A-wave duration is shorter 
than the pulmonary venous AR wave) (Anderson, 2004). 
 
Age is an important variable which affects the interpretation of diastolic filling profiles. 
Abnormalities of left ventricle diastolic function have been described as part of the normal 
ageing process resulting from intrinsic myocardial changes and hypertrophy of the left 
ventricle. Due to these changes in myocardial relaxation and compliance with ageing, 
different diastolic filling patterns are expected for different age groups. In the normal, young 
individual, left ventricle elastic recoil is vigorous and myocardial relaxation is swift. As a 
result, approximately 85-95% of left ventricle filling occurs in early diastole and only a small 
proportion of filling occurs with atrial contraction (5-15%) (Anderson, 2004). 
 
2.10  Diseases associated with diastolic dysfunction 
 
The major causes of diastolic dysfunction include: 
 
 Chronic hypertension 
 Hypertrophic cardiomyopathy 
 Aorta stenosis 
 Coronary artery disease 
 Restrictive cardiomyopathy eg. Amyloidosis. 
 Ageing 
 
However with regard to this study, the common confounding factors were limited to patients 
with clinical risk factors of alcohol consumption, smoking, hypertension, ischemia, 
cholesterol, diabetes and ageing affects as well as patients that are overweight and the 
researcher shall elaborate only on the above-mentioned risk factors in the literature review. 
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2.10.1     Alcohol 
 
The long term consumption of alcohol is linked to the weakening of the heart muscle known 
as cardiomyopathy (Ettinger et al., 1978). In a study done by “the Academy of Medical 
Science” in 2004 it was found that sporadic heavy drinking increases the risk of developing 
coronary heart disease, the most common form of heart disease (Ettinger et al., 1978). They 
also found that men nearly double their chances of developing coronary heart disease when 
they drink more than eight units of alcohol per day. They also found that women have a 1,3 
times greater risk in developing coronary artery disease if they consume more than 6 units of 
alcohol a day. 
 
Drinking too much has the following effects on the heart: 
Holiday heart syndrome: Ettinger and co-workers (1978) found that heavy alcohol 
consumption can cause a sudden irregular rhythm of the heart in apparently healthy people. 
This can result in shortness of breath, changes in blood pressure and an increase in the risk of 
a heart attack and even sudden death. 
Increased risk of thrombosis: it was found by Mc Kee and Britton (1998) that alcohol can 
affect the levels if homocysteine in the blood. This in turn increases the risk of coronary 
artery disease. 
Increase of blood pressure: According to the Department of National Health of Australia, 
men who regularly consume more than 8 units of alcohol a day have a four times higher risk 
of developing hypertension. Women who regularly consume more than 6 units of alcohol 
have double the risk of developing high blood pressure (Dept of Health, 2007). 
Enlargement of the heart: Regular heavy drinking may lead to heart failure (British Heart 
Foundation and Disease). 
 
2.10.2 Smoking 
 
Research done by McGill and co-workers (1963) has confirmed that smoking can damage the 
blood vessels. Atherosclerosis begins in childhood and progresses from fatty streak to raised 
lesions in adolescence and young adulthood (McGill et al., 1963; Stary, 1989; Strong et al., 
1963). 
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As individuals get older and enter middle age, raised lesions increase in size and continue to 
accumulate lipid and become susceptible to rupture of the fibromuscular cap and the 
overlying endothelium that can lead to occlusive thrombosis and ischemic injury to the brain 
or the heart (Constantinides, 1966; Fuster et al., 1992). They looked at the arteries of people 
15-34 years of age who died from car accidents, suicide or murder and they looked for 
evidence of fatty built up in blood vessels, and measured the levels of cholesterol as well as 
thiocyanate which are markers of cigarette smoking. They found that the smokers showed 
more early signs of atherosclerosis than the people that have never smoked. 
 
Ridolfe et al. (1998) found that smoking is one of the major risk factors for heart attack and 
the risk increases with length and intensity of exposure to cigarette smoke. They also found 
that in people less than 65 years of age it is estimated that 36% of men with coronary artery 
disease and 33% of women with coronary artery disease smoked.  
 
Cigarette smoking is considered as one of the most important correctable risk factors for 
cardiac morbidity and mortality (Holbrook et al., 1984; Zeiher et al., 1995). The immediate 
hazardous effects of smoking include, transient elevation of blood pressure and heart rate 
(Failla et al., 1997; Ijzerman et al., 2003). In a study done by Alam and co-workers (2002) 
they found a smoking-related decrease in transmitral early velocity, an increase in late 
velocity, and a decrease in the ratio between early and late velocities immediately after 
smoking cigarettes, compared with baseline values before smoking. 
 
2.10.3  Overweight 
 
Since 1970 the prevalence of obesity among children between the ages 2 and 5 years has 
doubled and that of children and adolescents between the ages of 6 and 19 years has tripled. 
More than 17% or 9 million children and adolescents in America are now considered 
overweight (Hedley et al., 2004; Ogden et al., 2006). 
 
An elevated body mass index is associated with several risk factors for heart disease 
including hypertension, dyslipidemia and diabetes (Freedman et al., 1999). 
 
Freedman and co-workers (2005) found that overweight adolescents are likely to become 
obese adults.  
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Obesity is a chronic medical problem with increased prevalence in the world today and is 
now recognised as a global epidemic (Flegal et al., 2002). The risk of a premature death is 
doubled in obese people when compared to non-obese individuals and the risk of death from 
cardiovascular disease is 5 times higher (Echel et al., 2005; Isomaa et al., 2003). 
 
Obesity is frequently associated with insulin resistance and is an independent risk factor for 
cardiovascular disease. Type 2 diabetes, hypertension and dyslipidemia are also found in 
association with insulin resistance. In a study done by Peverill et al. (2004) there were 
significant differences between septal E’ and S’ in their relationship to body size. The septal 
E’ was negatively, rather than positively associated with body size. Secondly, the septal E’ 
was not related to height but instead was associated with markers of fat-mass weight and 
BMI. Previous studies showed evidence that obesity is associated with abnormalities of 
diastolic function and that the effect of obesity may be independent of left ventricular mass 
(Chakko et al., 1991; Iacobellis et al., 2002). 
 
2.10.4  Hypertension 
 
Clinical and epidemiological studies have shown that a high proportion of patients with 
congestive heart failure have normal left ventricular ejection fraction (Devereux et al., 2000; 
Dougherty et al., 1984; O’Connor et al., 2000; Soufer et al., 1985). 
These patients have a high prevalence of arterial hypertension in which the presence of 
congestive heart failure has widely been attributed to isolated diastolic dysfunction. These 
hypertensive patients have shown a high prevalence of diastolic dysfunction on 
echocardiographic studies done on them (Rusconi et al., 2001; Wachtell et al., 2000). 
Commonly used parameters for measuring left ventricle systolic function are the ejection 
fraction and the shortening fraction; however, these parameters may have limitations as 
measurement of contractile properties of the left ventricle.  The global assessment of left 
ventricle performance by means of ejection fraction does not take regional contractile 
function into consideration, and fractional shortening primarily reflects radial contraction of 
the left ventricle caused by the circular myocardial fibres (Poulsen et al., 2003). 
 
Abnormal diastolic left ventricular filling is frequently found in patients with hypertension 
(Wahtell et al., 2000). Previous studies showed decreased left ventricle peak systolic 
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velocities in patients with hypertension and hypertrophy (Pela et al., 2001; Vinereanu et al., 
2001). 
 
2.10.5 Cholesterol 
 
Cholesterol is one of the fats in the body that is used to make new cell membranes as well as 
vitamin D and hormones and without it our bodies will not function (McPherson et al., 2006). 
There are two main types of cholesterol according to the Heart and Stroke Foundation. 
 
Low-density lipoprotein (LDL) cholesterol – often called “bad” cholesterol because high 
levels of LDL-cholesterol in the blood promote the build-up of plaque in the artery walls. 
High-density lipoprotein (HDL) cholesterol – often called “good” cholesterol because it helps 
carry LDL-cholesterol away from the artery walls. 
 
Coronary artery disease is the most common form of heart disease and is caused by build-up 
of plaque, which is made up of cholesterol, fatty compounds, calcium and fibrin (Texas Heart 
Institute, 2005). 
 
2.10.6 Ischemia 
 
Coronary artery disease causes loss of myocardial contraction with subsequent systolic 
distension in the region being deprived of blood supply (Tennant et al., 1935). This is 
reflected by abnormalities in the wall thickening and the motion of the wall demonstrated by 
echocardiography, which has become a clinically important method for detecting regional 
ischemia (Inoue et al., 1971; Quinones et al., 1974). 
 
2.10.7 Diabetes  
 
Diabetes mellitus is a major risk factor for increased cardiovascular risks in all patients and 
increases the morbidity and mortality rates (Stamler et al., 1993). Diabetic cardiomyopathy 
was described as a disease entity in patients with insulin-dependent diabetes mellitus (Attali 
et al., 1988; Galderisi et al., 1991). Despite all known factors for cardiovascular disease and 
diabetes mellitus the prevalence of myocardial systolic and diastolic functional abnormalities 
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in asymptomatic patients with non-insulin-dependent diabetes mellitus is not well defined 
(Annonu et al., 2001). 
 
2.11           Tissue Doppler 
2.11.1       Introduction  
 
The development of tissue Doppler imaging rendered the echocardiographic evaluation of left 
ventricular function more comprehensive (Miyatake et al., 1995 Sutherland et al., 1994). The 
study of the mitral valve annulus motion with echo-M-mode and tissue Doppler allows the 
detection of systolic and diastolic changes of the left ventricular long axis shortening (Gulati 
et al., 1996), which had previously been poorly studied because of technical and 
methodological difficulties.  Moreover, wall motion analysis by tissue Doppler is a promising 
method for evaluating left ventricular filling, which has been traditionally studied 
noninvasively by the transmitral Doppler flow. At present, studies evaluating left ventricular 
function by echo-tissue Doppler, either in healthy individuals or in patients with heart 
disease, are still incomplete (Garcia et al., 1996; Gulati et al., 1996; ; Heinen et al., 1999;  
Miyatake et al., 1995; ; Sohn et al., 1997; Sutherland et al., 1994; Zamorano et al., 1997). 
 
Tissue Doppler imaging has evolved to become a useful noninvasive method that can 
complement other echocardiographic techniques in the assessment of left ventricular 
myocardial velocities in a variety of clinical conditions (Waggoner et al., 2001). 
 
Conventional Doppler echocardiography permits the determination of the velocity and 
direction of blood flow through the heart and great vessels throughout the cardiac cycle as a 
function of time. Doppler tissue imaging (DTI), on the other hand, records systolic and 
diastolic Doppler velocities within the myocardium and at the corners of the mitral annulus 
(Anderson, 2004). 
 
2.11.2 Physiology of tissue Doppler imaging  
 
Mitral-inflow pulsed-wave Doppler is the standard echocardiographic method for assessment 
of left ventricular diastolic function. The technique measures intracavity gradients, which are 
dependent on left ventricular relaxation, preload, and end-systolic volume, and atrial and 
ventricular stiffness (Appleton et al., 1988; Nishimura et al., 1989). Doppler tissue imaging 
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(DTI) is a new technique that enhances low velocity, high-amplitude signals of myocardial 
motion and allows direct quantification of myocardial velocities (Donovan et al., 1995; Palka 
et al., 1995; Garcia et al., 1996; Hada et al., 1996) and assessment of regional myocardial 
systolic and diastolic function (Bach et al., 1996; Derumeaux et al., 1998).  
 
Peak early myocardial diastolic velocity is relatively load-dependent and provides assessment 
of left ventricular filling pressure (Nagueh et al., 1997). It correlates with the time constant of 
isovolumetric relaxation (Oki et al., 1997; Oki et al., 1998). Myocardial velocities provide 
additional value over mitral or pulmonary vein inflow indices and differentiate pseudo 
normal from a normal Doppler mitral inflow pattern (Farias et al., 1999; Sohn et al., 1997).  
Firstly, conventional Doppler echocardiography sets filters to detect signals within the range 
of intracardiac blood flow velocities (15 to 100 cm/s). Secondly, the amplitude of signals 
arising from moving blood cells is fairly low (0 to 15 dB). 
 
However, myocardial Doppler signals have important acoustic differences compared with 
blood. Firstly, myocardial wall motion velocity is much slower than blood flow velocity 
(usually less than 10 cm/s). Secondly, the Doppler signal intensity of wall motion is much 
greater than that of the Doppler signals arising from red blood cells (greater than 40 dB). For 
these reasons, adjustments must be made to record low-velocity, high-intensity myocardial 
signals (Azevedo et al., 1997). 
 
Myocardial DTI E/A wave ratio is helpful in the early assessment of diastolic dysfunction in 
patients with hypertension (Azevedo et al., 1997), in transplantation rejection (Puleo et al., 
1998), and in diagnosis of restrictive cardiomyopathy (Garcia et al., 1996). Besides decreased 
amplitude of diastolic myocardial motion, left ventricular hypertrophy leads to delay in onset 
and slowing of left ventricle diastolic relaxation (Nishimura et al., 1989; Appleton et al., 
1998). The influence of left ventricular hypertrophy with preserved systolic function on the 
duration of myocardial diastolic velocities has not been determined (Tasneem et al., 2001).  
 
Doppler assessment of left ventricular filling and more recently pulmonary venous flow have 
been used to estimate different parameters of left ventricular diastolic function, including left 
ventricular filling pressure, relaxation, and stiffness (Appleton et al., 1988; ; Hoit et al., 1994; 
Labovitz et al., 1987; Nishimura et al., 1989). Analytical models, animal experimentation, 
and human studies have demonstrated that not only the rate of isovolumic ventricular 
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relaxation but also preload, end-diastolic volume, and atrial and ventricular stiffness are 
determinants of standard pulsed Doppler filling indexes (Appleton et al., 1993; Choong et al., 
1987; Choong et al., 1988; Thomas et al., 1991). Impairment of left ventricular relaxation 
results in prolongation of the isovolumic relaxation time, reduction in early transmitral flow 
velocity (E) with prolongation of the E-wave deceleration time, increased atrial contraction 
velocity, and increased systolic (S) pulmonary venous flow (Basnight et al., 1991; Nishimura 
et al., 1997). 
 
In contrast, increasing filling pressure shortens isovolumic relaxation time, increasing early 
transmitral gradient and transmitral flow velocities, and reducing early flow deceleration 
time, atrial contraction velocity and pulmonary vein systolic flow. Hence, all the standard 
pulsed Doppler filling indexes change in a typical parabolic or U-shaped pattern during the 
progression from normal to severe diastolic dysfunction (Appleton et al., 1988; Little et al., 
1995). Determining whether a specific Doppler pattern corresponds to a patient in “left” 
versus the “right” limb of the parabola is often difficult unless other relevant clinical and/or 
invasive information is available (Appleton et al., 1992; Choong et al., 1988; Colan et al., 
1985; Ishida et al., 1986).  
 
Doppler tissue echocardiography is a recent Doppler application that allows direct 
measurement of myocardial velocities. In one approach, the velocities of left ventricular 
motion in its axial plane are obtained by interrogating the basal myocardial segment near the 
mitral annular region from the apical acoustic window (Garcia et al., 1996; Isaaz et al., 
1993;). Peak early diastolic myocardial velocity has been shown to correlate well with the 
time constant of isovolumic relaxation (Oki et al., 1997) and appears to be relatively 
independent of preload (Sohn et al., 1997). 
 
Doppler myocardial velocities have been found to be clinically useful in differentiating 
patients with restrictive cardiomyopathy from those with constrictive pericarditis in whom 
left ventricular relaxation is normal (Garcia et al., 1996). Movement and velocities of cardiac 
structures are related to underlying systolic and diastolic function of the heart. Tissue Doppler 
provides a means for measuring and displaying cardiac wall motion velocities. Tissue 
velocities are lower (5 to 20 cm/s) than blood-flow velocities. Although tissue velocities with 
low frequency are filtered during conventional Doppler recording of blood-flow velocities, 
tissue Doppler rejects high frequencies to measure wall motion velocities. 
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Tissue Doppler velocities can be recorded directly or can be auto correlated to a colour 
scheme (Oh et al., 1999). Isaaz et al. (1989) were able to obtain a pulsed Doppler profile of 
the left ventricle posterior wall, and this concept was expanded by McDicken et al. (1992), 
who developed a prototype of colour Doppler velocity display of myocardial wall dynamics. 
Since these reports, tissue Doppler imaging of normal and abnormal wall motion has been 
reported. Several investigators have used tissue Doppler to evaluate regional and global 
diastolic function in the setting of acute ischemia and diastolic heart failure (Fernandez et al., 
1998), and it has been noted that mitral annulus velocity measured by tissue Doppler is an 
indicator of myocardial relaxation, relatively unaffected by preload or afterload. This 
property of mitral annulus velocity appears to be useful in estimating left atrial pressure in 
conjunction with mitral inflow E velocity (Oh et al., 1999). 
 
Doppler tissue imaging or tissue Doppler has been applied to evaluate diastolic function by 
measuring mitral annulus velocity during diastole. The mitral annulus velocity profile during 
diastole reflects the rate of changes in the long-axis dimension and in left ventricle volume. 
When myocardial relaxation is abnormal, the ratio of mitral annulus motion during atrial 
systole to the total diastolic annular motion is increased (Oh et al., 1999). Sohn et al. (1997) 
demonstrated that mitral annulus velocity determined by DTI is relatively preload-dependent 
and is useful in differentiating pseudo normal (grade 2 diastolic dysfunction) from normal 
mitral inflow velocity pattern. Mitral annulus velocities are markedly decreased in patients 
with restrictive cardiomyopathy, which is clinically useful in distinguishing it from 
constrictive pericarditis, which has a preserved mitral annulus velocity (Garcia et al., 1996). 
 
Using the early diastolic velocity of the mitral annulus (E’) as pre-independent index of left 
ventricle relaxation, E/E’ has been found to correlate well with mean pulmonary capillary 
wedge pressure (Nagueh et al., 1997). Tissue Doppler echocardiography allows for 
quantitative measurement of myocardial motion. Mitral annulus velocity in diastole is 
reflective of changes in velocity for the left ventricle long axis. In normal hearts, the long axis 
and circumferential motion are approximately the same. By recording mitral annulus motion 
from the apex, the effect of myocardial translation is minimised. A typical spectral pattern 
will demonstrate a single systolic velocity towards the left ventricle centroid (Sm) and two 
signals away from the centroid during early (Em) and late (Am) diastole. 
This method appears to be relatively insensitive to preload; therefore it may help differentiate 
normal from pseudo normal filling. With abnormal active relaxation, mitral annulus motion 
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during diastole (atrial systole) is increased. Mitral annulus velocity is markedly reduced with 
restrictive cardiomyopathy, but with constrictive pericarditis, the velocities are preserved.  
 
With ageing the Em:Am (Fig 2.7) ratio decreases. For mitral annulus spectral recordings the 
pulse-wave sample box should be 3-7 mm, the TDI function activated, Doppler gain reduced 
and wall filters minimised. At the mitral annulus the sample box may be placed in the 
septum, lateral, anterior of inferior aspects to help differentiate pseudo-normal from normal 
filling. For the young, normal Em is greater than 10 cm/s, and for adults normal Em is greater 
than 8 cm/s. For abnormal relaxation, pseudo-normal and restriction to filling Em should be 
less than 8 cm/s (Kerut et al., 2004). 
 
 
Fig. 2.7  Myocardial velocities recorded from apical view include apically directed systolic   
velocity (Sm wave), atrially directed early myocardial lengthening velocity (Em 
wave), and atrially directed late myocardial lengthening velocity (Am wave). Less 
prominent biphasic velocities were seen during isovloumic contraction and relaxation 
phases as well. 
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2.11.3 Methods for obtaining tissue Doppler images 
 
Current DTI settings measure velocities in a range of 0.2-40 cm/s and detect amplitudes of 
greater than 20 dB. 
DTI velocities may be displayed as either spectral PW Doppler velocities or colour-encoded 
M-mode or 2-D mode. However, for the purpose of diastolic function assessment, DTI 
velocities are best displayed as spectral PW Doppler velocities because this modality 
provides high temporal and velocity range  resolution as well as displaying quantitative 
velocity information. Myocardial velocities can be recorded by placing the PW Doppler 
sample volume at the lateral corner of the mitral annulus from the apical four-chamber view. 
Myocardial velocities may also be recorded from the septal side of the mitral annulus 
manner. When recorded from the apical views, the myocardial velocities are composed of 
three components. These components include:  
 An apically directed systolic myocardial velocity (Sm): 
 An early diastolic atrially directed myocardial velocity (Em): and 
 A late diastolic atrially directed myocardial velocity (Am). 
 
In addition to these three distinct velocities (Fig. 2.7), less prominent biphasic velocities can 
be seen between the Sm and Em waves during left ventricular isovolumic relaxation period 
and between Am and Sm waves during the isovolumic contraction period. Since the velocity 
of annular motion reflects shortening and lengthening of the myocardial fibres along a 
longitudinal plane, it has been suggested that the early diastolic velocity recorded at the septal 
or lateral corner of the mitral annulus can provide an index of left ventricular relaxation 
which is not affected by the LA pressure (Anderson, 2004). In particular, it has been 
suggested that the Em can be used in the differentiation between normal and pseudo-normal 
filling profiles (Farias et al., 1999; Nagueh et al., 1997). 
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Table 2.1  Normal values for the mitral annulus velocities derived by DTI 
Author (year) PT NO. Sampling site Em velocity (cm/s) Am 
velocity(cm/s) 
Sohn et al.,  
1997 
59 Septal side 10.0 ± 1.5 9.5±1.5 
Nagueh et al., 
1997 
34 Lateral side  12 ± 2.8 8.4 ± 2.4 
Farias et al., 
1999 
27 average 16.0 ± 3.8 11.0 ± 2.1 
PT (Patient numbers); Em (initial muscle relaxation); Am (atrial contraction muscle 
relaxation) 
 
Table 2.2 Values of the mitral Em velocity (initial muscle relaxation) derived by 
DTI separating abnormal relaxation, pseudonormal, and restrictive 
physiology from the normal 
 
Author (Year) Normal Abnormal 
relaxation 
Pseudonormal Restrictive 
physiology 
Nagueh et al., 
1997 
12 ± 2.8 5.8 ± 1.5 5.2 ± 1.4 _ 
Farias et al., 
1999 
16.0± 3.8 7.5 ± 2.2 7.6 ± 2.2 8.1 ± 3.5 
 
Isaaz et al. (1989) first reported the use of TDI in the evaluation of left ventricular function 
with pulsed Doppler recordings of intramyocardial velocities in the posterior wall. The use of 
colour TDI, including M-mode and 2-dimensional instrumentation, was subsequently 
reported by Sutherland et al. (1994). Tissue Doppler imaging methods have required 
modifications in signal processing of the returned Doppler signals. The high-pass wall filters, 
which are used to eliminate the low-velocity and high-amplitude signals of myocardial walls 
for detection of blood flow velocities in conventional Doppler/colour-flow modalities, are 
bypassed for TDI. In addition, gain amplification is used to enhance low-velocity myocardial 
signals and eliminate the blood flow signals within the cardiac chambers (Sutherland et al., 
1999). 
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When pulsed-wave TDI is performed, spectral gain settings often must be reduced to 
optimally record the low-velocity and high-intensity signals from the myocardial walls. 
Because the myocardial velocities are low (<25 cm/s), an appropriate scale must also be 
incorporated to obtain proper display and accurate measurements (Waggoner et al., 2001). 
When colour TDI is used, the 2-dimentional imaging gain must be reduced for optimal colour 
display of myocardial velocities. To display myocardial velocities, colour TDI employs 
autocorrelation methods, similar to those used for conventional colour-flow imaging 
(Waggoner et al., 2001).  
 
Preset TDI controls are present on some ultrasonographic systems and should be used for 
proper acquisition of myocardial velocities. It is particularly important that the system is 
optimised to filter out the high-velocity signals of blood flow within the cardiac chambers 
and display only the low-velocity and high-amplitude signals of the wall motion velocities. A 
2.5 to 4 MHz transducer should be used for imaging (Waggoner et al., 2005). When using 
colour TDI, the colour sample window can be placed within a specific wall segment to be 
analysed or placed to encompass the entire area of the left ventricle image. After image 
acquisition and digital storage, further analysis can be completed off-line by novel software 
programmes (Waggoner et al., 2001). 
 
Pulsed TDI, as opposed to colour TDI, offers improved temporal resolution and the ability to 
quantify peak rather than mean myocardial velocities. It does not require off-line analysis, 
and it provides instantaneous display of the Doppler spectral information. A small sample 
volume (2 mm axial length) is used for accurate placement in the myocardium within the 
boundaries of the endocardium and epicardium. The sample gate can be placed at any site 
within the 2-dimensional image in either parasternal or apical windows. Pulsed TDI has 
limitations because only regional quantification of myocardial velocities can be done at 
selected sites, and sampling cannot be localised to the endocardial or epicardial layers 
(Sutherland et al., 1994). 
 
When using pulsed TDI, the preset function should be employed if it is available on the 
ultrasonographic system. The myocardial area of interest to be assessed should be placed in 
the centre of the ultrasound beam for parallel alignment of the sample cursor. The Nyquist 
limit should range from 20 to 30 cm/s, with a minimum gain and low wall filter settings. The 
monitor sweep speed should be set at 50 to 100 mm/s to optimise the spectral display of 
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myocardial velocities (Pellerin et al., 1999; Uematsu et al., 1995). Colour or pulsed TDI 
performed in parasternal long-or short-axis views enables assessment of the anteroseptal or 
inferoposterior left ventricle wall velocities with pulsed Doppler, colour TDI, or colour M-
mode echocardiography.  
 
Colour TDI is visually appealing and discloses differential velocities between the 
subendocardial and subepicardial layers during systole and diastole (Uematsu et al., 1995; 
Pellerin et al., 1999) (Table 2.1). Colour M-mode TDI can be superior to 2-dimensional 
colour TDI for the temporal display of these velocity differences, but it is limited because of 
the M-mode cursor orientation in most systems. With colour TDI, a higher velocity of 
shortening and relaxation can be observed in the endocardium compared with the epicardium, 
and it can be quantified as a myocardial velocity gradient (Pellerin et al., 1999; Uematsu et 
al., 1995). Myofibre orientation in the anteroseptal and posterior myocardial regions in the 
parasternal long-axis view is perpendicular to interrogation with TDI methods. As such, the 
quantification of myocardial velocities may be influenced by angle, excessive motion of the 
heart anterior in the chest, and cardiac translation (Pellerin et al., 1999; Uematsu et al., 1995).  
 
An alternative approach includes the use of pulsed TDI in the apical views. The apical 
imaging approach is feasible in most patients and provides a method for the assessment of 
left ventricle long-axis shortening and lengthening. Typically, pulsed Doppler sampling is 
performed in the basal regions of the left ventricle, adjacent to the mitral annulus, for 
assessment of regional systolic and diastolic myocardial velocities in the lateral, septal, 
anterior, and inferior walls and the anteroseptal and posterior segments (Azevedo et al., 1996; 
Gulati et al., 1996; Rodriguez et al., 1996). Recent investigators have reported that pulsed 
TDI measurement of myocardial velocities also can be obtained in the mid and apical regions 
of the left ventricle. Adequate myocardial velocities signals are sometimes difficult to obtain 
in these segments, particularly in the apex (Galiuto et al., 1998; Pai et al., 1998).  
 
The motion of the mitral annulus can be assessed with TDI for determination of global left 
ventricular systolic function, similar to the manner in which conventional 2–dimensional or 
M-mode imaging provide measurements of the descent of the base (Pai et al., 1991; 
Simonson et al.,1989). 
Myocardial velocities recorded with pulsed TDI have 3 main components. These include 
systolic, early diastolic and late diastolic velocities. Directionality of the TDI velocity display 
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is dependent on location of the pulsed Doppler sample volume relative to the myocardial site. 
The systolic myocardial velocity (Sm) may show 2 components in some patients, 
representing isovolumic contraction and the systolic ejection phase. The diastolic component 
is very similar in appearance and timing to mitral flow velocities obtained with conventional 
pulsed Doppler: an early diastolic myocardial velocity (Em) at the time of atrial contraction.  
 
Both Em and Am are present in sinus rhythm, but during atrial fibrillation or tachycardia, Am 
may not be evident. In addition, an isovolumic relaxation velocity can be seen. Measurements 
include Sm, Em and Am and the ratio of Em/Am (Table 2.2). Time intervals of isovolumic 
contraction and relaxation may have application for regional function. Pulsed TDI may be 
influenced by cardiac translation, but the effect is lessened with the use of apical windows 
(Waggoner et al., 2001). 
 
Otto (2004) also explained that on 2D echocardiography, the mitral annulus moves towards 
the ventricular apex in systole, with the magnitude of this motion proportional to the extent of 
shortening in the ventricular length, a useful measure of overall left ventricular systolic 
function. Normal subjects have motion of the mitral annulus toward the apex equal or greater 
than 8mm, with a mean value of round and about 12 (2) mm in both four and two chamber 
views. 
 
The sensitivity of mitral annulus motion < 8 mm is 98% with a specificity of 82% for 
identification of an ejection fraction < 50% (Otto, 2004). 
 
2.12  Muscle Performance Index 
2.12.1       Introduction 
 
An index of myocardial performance has been devised to incorporate both systolic and 
diastolic time intervals in expressing global ventricular performance (Tei et al., 1995). The 
index of myocardial performance incorporates both systolic and diastolic time intervals for 
evaluation of global ventricular performance. Whereas systolic dysfunction will result in a 
prolonged isovolumic contraction time and a shortened ejection time, both systolic and 
diastolic dysfunction results in a prolonged isovolumic relaxation time (Kerut et al., 2004). 
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Myocardial performance index is a noninvasive, quantitative, Doppler-based measure of 
global cardiac function, which integrates systolic and diastolic function (Dandel et al., 2004; 
Tei et al., 1995). Muscle performance index is a ratio derived by the sum of isovolumic 
contraction time and isovolumic relaxation time divided by left ventricle ejection time (Fig. 
2.8). The normal value for this parameter has been determined to be 0.39 ± 0.05 (Tei et al., 
1995). 
 
 
Fig 2.8  Method used for calculating left ventricular index of myocardial performance, 
defined as (a-b)/b, whereas A is interval between cessation and onset of mitral 
inflow, and b is ejection time (ET) of LV outflow. Isovolumic relaxation time 
(IRT) is measured by subtracting interval between R wave and onset of mitral 
flow. Isovolumetric contraction time (ICT) is obtained by subtracting IRT from 
(a-b). Reproduced with permission (Adapted from Tei et al., 1996) 
 
2.12.2   Importance of muscle performance index 
 
In one third of patients with congestive heart failure, signs and symptoms of heart failure 
have been attributed to isolated diastolic dysfunction (Grossman et al., 1991). In these 
patients, the prevalence and annual mortality differ from those of patients with other forms of 
cardiac failure (European Study Group et al., 1998; Nishimura et al., 1997;   Zile et al., 
1999). Consequently, diastolic heart failure has emerged as a separate clinical entity within 
the last 15 years (European Study Group et al., 1998; Nishimura et al., 1997;   Zile et al., 
1999). Published criteria for diastolic heart failure are the presence of signs or symptoms of 
heart failure, evidence of abnormal relaxation or filling, and an ejection fraction of at least 
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45% (European Study Group et al., 1998). The Tei index (or muscle performance index) has 
been found to be a valuable quantitative echocardiographic index of ventricular function by 
incorporating both systolic and diastolic performance of the right and left ventricles (Tei et 
al., 1997). 
 
It is defined as the sum of isovolumic contraction and relaxation times divided by the ejection 
time, which requires measurement of the time interval between the end and onset of mitral or 
tricuspid inflow and the ejection time of the left ventricle or right ventricle outflow. Currently 
employed  measurements of systolic function are dependent on preload, such as ejection 
fraction, and non-invasive measurements of diastolic function are still being established. 
Nonetheless, the Tei index is easy to perform, reproducible, and independent of heart rate and 
blood pressure (Harada et al., 1998; Harjai et al., 2002). It is relatively independent of age 
and also has a low degree of interobserver and intraobserver variability (Harjai et al., 2002). 
In adults, the Tei index correlates well with invasive measures of left ventricular systolic and 
diastolic function (Harada et al., 1998; Eidem et al., 2001; Harjai et al., 2002). It is also a 
sensitive indicator of overall cardiac dysfunction in patients with mild to moderate congestive 
heart failure. The Tei index is particularly useful in congenital heart disease, where the 
anatomy may not be suitable for conventional methods of assessing ventricular function 
(Eidem et al., 1998; Williams et al., 2000). 
 
2.12.3    Information on the subject 
 
Small population-based studies have shown that muscle performance index (MPI) 
independently predicts mortality after myocardial infarction (Poulsen et al., 2000; Moller et 
al., 2001; Symanski et al., 2002; Moller et al., 2003; Sasao et al., 2004; Yuasa et al., 2005).  
Systematic evaluation of the influence of heart rate, changes in preload or afterload, and 
alterations in contractility on MPI have not been performed in the normal or dysfunctional 
left ventricle. More often, previous studies (Bruch et al., 2000) have correlated ambient heart 
rate with MPI for groups of patients with normal and abnormal function. Despite this 
limitation, heart rate had little effect on both normal and abnormal left ventricle function. 
Similarly, the effects of preload were assessed by tilt test in theatre, which was confirmed in a 
study done by Lavine et al. (2005). Increasing the preload resulted in an increase in 
echocardiographic left ventricular size with a decline in index of myocardial performance. 
The components of the index of myocardial performance were not addressed in this study. 
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Lavine et al. (2005) also noted a reduction in the index of myocardial performance but with 
acute shortened IVRT and chronic left ventricle dysfunction (prolonged left ventricle ejection 
time). 
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Chapter 3 
3.1          Aim of the study 
 
The study examined the presence or frequency of systolic and diastolic changes in a 
cardiology practice and secondly it examined the effects that certain clinical risk factors   
may have on their systolic and diastolic profiles, if any. 
 
 3.2         Study Objectives 
 
The objectives of this study were: 
 To determine the occurrence of systolic changes in a specific cardiology practice;  
 To determine the occurrence of diastolic changes in a specific cardiology practice; 
 To determine the effects of age and body composition on the systolic and diastolic 
parameters; and 
 To determine the influence of certain clinical risk factors on the systolic and diastolic 
parameters. 
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Chapter 4 
Methodology 
 
4.1 Study design 
 
The study design is cross-sectional descriptive study. Variants of analysis were used. 
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4.2 Study lay-out diagram 
 
See below the study lay-out of the research project (fig. 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  4.1  Study lay-out of the research study 
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4.3  Study plan 
 
The study was conducted at a Cardiology private practice at Medi-Clinic in Bloemfontein. 
The study was carried out on 112 patients who gave informed consent and fit the inclusive 
criteria during period July-October 2007. An Echocardiogram was done once off on all 
patients with an ECG connected. A patient data sheet was completed and analysed. 
 
4.4            Study Population 
4.4.1        Sample size  
 
It was expected that 60 % of the total study population would have systolic or diastolic 
abnormalities. The study population was divided into 3 age groups: 
Group 1:  Patients with an age range between 20 and 40 years old. (Younger) 
Group 2:  Patients with an age range between 41 and 60 years old. (Middle age) 
Group 3:  Patients with an age range between 61 and 80 years old. (Elderly) 
 
Group 1 was considered as the control group because they were recruited students from the 
local university and was not seen as patients in the cardiology practice, the reason for this 
being to test changes in the older group against variables in the younger group as reference 
when analysing the effect of ageing. 
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4.4.2 Inclusion criteria 
 
 South Africans citizens 
 Male and female patients were evaluated 
 Their age between 20 and 80 years. 
 Patients that are in sinus rhythm.  
 Patients must have a technically adequate echocardiogram. 
 No evidence of infarction or infarction areas on the echocardiogram. 
 No conduction abnormalities or ventricular ectopy. 
 No patients with other diseases that may influence the study parameters. 
 Only patients that consented to participate in the study were used.  
 
4.4.3 Exclusion criteria 
 
 Technically inadequate images. 
 Poor quality echocardiogram. 
 Patients who do not give consent. 
 Patients with regional wall motion abnormalities. 
 Patients with acute infarction. 
 Patients with lung disease. 
 Patients with valve disease. 
 Pregnant patients. 
 Patients who are on beta-blockers. 
 Patients with a conduction delay abnormality on the ECG. 
 Patients in atrial fibrillation. 
 Patients with previous bypass operation. 
 Patients with an implanted pacemaker. 
 Patients that take any medication that may influence the measurements to be 
done. 
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4.4.4 Justification for inclusion and exclusion criteria 
 
 For ethical and confidential reasons all the patients gave their consent to 
participate in this study. 
 Patients must be in sinus rhythm because an abnormal rhythm influences 
the measurements of systole and diastole. 
 The patients should have adequate images because the importance of 
accurate measurements. 
 They should use no medication because that can influence diastolic 
parameters. 
 No conduction abnormalities or previous infarction was included because 
that influenced measurement of the diastolic or systolic parameters. 
 Patients with lung disease were not included in the study because of its 
influence on the diastolic measurements. 
 Valve disease patients were excluded because it changed the diastolic 
components of the cardiac cycle. 
 No pregnant patients were included due to overexposure of ultrasound. 
 No patients with previous bypass or pacemaker operations were included 
because of segmental changes on the heart muscle. 
4.4.5  Withdrawal criteria 
 
The patients could withdraw from this study at any stage. The patient’s withdrawal will not 
be held against him/her and treatment at the Cardiologist will continue as if he/she had never 
enrolled in this study. No patients withdrew from the study and no dropouts were recorded 
during the study period. 
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4.4.6  Subject identification 
 
The study subjects were identified using the same code that is usually used to file the 
echocardiograms in this practice, namely by using the first three letters of the subject’s 
surname, the first initial and the year of birth. For the purpose of the study, an extra number 
was added that fits the consent form’s number.  
 
4.5          Study variables 
 
The research study is very safe. There are no adverse affects from doing an echocardiogram 
on a patient. The information obtained from the tests done on the patients was kept strictly 
confidential and were available only to the researcher and the cardiologist treating the patient. 
 
4.6  Financial implications 
 
There was no financial implication for the study subjects other than their normal consultation 
fee. There were no financial implications for the private practice where the echocardiography 
was done because no new equipment needed to be bought and the necessary equipment was 
already available in the practice. The normal consultation examination was followed, but for 
the study additional measurements were done. There were  no financial implications for  the 
patients. The patient or his/her medical aid was only liable for the normal consultation fee to 
the cardiologist. 
 
4.6  Premature discontinuation of the study 
 
The study was not discontinued prematurely. Neither the researcher nor any other of the 
study leaders felt that a patient’s confidentiality was breached and no unethical procedures 
occurred.  
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4.8  Methods used for data collection 
 
 During the routine consultation an echocardiogram was performed on the patient as part 
of the normal cardiological examination. An ECG was connected to the patient’s chest. 
 This test was done by the researcher, who is a senior clinical technologist in cardiology 
and echocardiographer. 
 The patient’s height and weight were measured on a scale with height measure band and 
the body mass index was calculated. 
 An ECG was connected as part of the echocardiography examination and used in the 
measurements of systolic and diastolic function. 
 All the above-mentioned data were recorded and written down on the data sheet 
(Appendix C). 
 Left ventricular ejection fraction was measured as well as the shortening fraction and all 
the systolic flow velocities using the Doppler echocardiography and tissue Doppler 
echocardiography. 
 Left ventricle diastolic measurement was done using Doppler echocardiography and 
tissue Doppler echocardiography. 
 The left ventricular mass was measured according to the recommendations of the 
American Society of Echocardiography (2005). 
 The appropriate method for measuring mitral valve inflow is to use a two-dimensionally 
directed pulsed sample volume placed at the tips of the mitral valve. This is the point at 
which the mitral flow velocities are maximal.  
 The ultrasound beam needs to be parallel with the direction of blood flow and the lowest 
possible filter settings were used to ensure that a full and complete Doppler flow signal 
was obtained  
 To measure left ventricle isovolumic relaxation time the interval from aortic valve closure 
to mitral valve opening, a 3-4 mm size sample volume was placed in the area of the mitral 
leaflet tips.  
 The patient was asked to exhale and keep his/her breath for a while during which the 
diastolic measurement was taken. 
 Three beats were analysed and the mean value was taken of each of the separate values. 
 All the above data were collected and included on the data sheet (See Appendix C). The 
patient’s age was determined and also included into the data sheet.  
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 All the above-mentioned patients were weighed against the inclusion and exclusion 
criteria. Those who qualify were asked to give their written consent.  
 All data on the echocardiography datasheets (Appendix C) were then processed and 
analysed. 
 The data were analysed with the help of the Department of Biostatistics at the University 
of the Free State. 
 
4.9  Apparatus 
 
A Toshiba Powerplus 6000 echocardiographic machine with a 2.5-3.7 MHz transducer and 
adult package software was used in the measurements of all the parameters of systolic and 
diastolic function and the measurement of the index of myocardial performance.  The 
machine also has the following facilities available: 
 The measurement of tissue Doppler images. 
 An ECG was connected to the patient so that gated measurements can be done. 
 Have measurement analysis packages to analyse all the parameters. 
All the other data were analysed afterwards using a commercially available, scientific 
calculator.  
 
4.10  Special investigation (echocardiogram) 
 
The researcher conducted all the measurements and did the echocardiogram. 
The standard positioning of the patient in the partial left decubitus position with the head of 
the bed elevated by 30 degrees was used. 
 
An ECG was connected by the researcher himself to determine if it matched any excluding 
criteria regarding any arrhythmia or conduction abnormalities. The ECG is also of 
importance when measurement for this study is done. 
 
Normal echocardiography was done on all subjects. They underwent normal M-Mode and 2D 
and colour sonography to determine normal anatomical and physiological parameters. 
Left ventricular measurements were taken just below the mitral valve tips. Measurements of 
the left ventricular mass using the recommendations of the American Society of 
Echocardiography (Sahn et al., 1978) were performed. Measurements of the interventricular 
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septum and the internal dimension and the posterior wall thickness of the left ventricle at end-
diastole according to the ECG was conducted and written down on the data sheet. 
 
Doppler echocardiography (Oh et al., 1997) was conducted, placing the sample volume at the 
tips of the mitral valve opening at the narrowest point in a four chamber view. The patient 
was asked to stop breathing and measurements of the trans-mitral inflow were taken. 
Measurements of the E wave, deceleration time, isovolumetric relaxation time, and the A 
wave were performed and included on the data sheet. 
Tissue Doppler imaging of the annular septum and posterior wall was conducted and 
measurements of the Em velocity, Am velocity and the Sm velocity were performed and 
included on the patient’s data sheet. 
 
In this study the use of different systolic and diastolic measurements were conducted on the 
patients and the researcher analysed those changes in a statistical manner to also determine 
the individual changes of those specific parameters and the effects they had on the muscle 
performance index.  The measurement of the muscle performance index was conducted 
according to a standardized formula (See Fig. 2.8). 
 
All measurements of this index were included in the patient data sheet (Appendix C). 
The left ventricle ejection fraction was measured by using the Teicholtz formula (Teicholtz et 
al., 1976). 
 
4.11  Statistics 
 
A multi-variant analysis was done on the data. The data obtained from this study were 
analysed by an independent Biostatistician of the University of the Free State.  Numerical 
variables were summarised by means, standard deviations or percentiles, depending on the 
data distribution. Categorical variables were summarised by frequencies and percentages. 
Differences between the groups were summarised using 95% confidence intervals for 
differences in means, medians or percentages.  
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4.12           Ethics 
4.12.1   Ethical approval  
 
Ethical approval for the research project was obtained from the Ethics Committee of the 
University of the Free State (ETOVS nr 95/07). 
 
4.12.2       Consent form 
 
Consent was needed from the physician to use the patients in his practice. A consent form 
had to be signed by all research subjects to be included in the study. All the patients were 
informed about the purpose of the study, and that there would be no extra financial burden on 
them, as well as that there would be no adverse effects and that this study will not have any 
implication on their normal treatment regime. 
 
The researcher explained the consent form to the patients in English and Afrikaans.  The 
patients decided in which language he/she wanted to sign the form. An information sheet in 
Afrikaans and English were available to all the study subjects. An example of the information 
sheet and the consent form are included in Appendix A and B. 
 
4.12.3 Confidentiality 
 
The confidentiality of this study was very important. None of the information obtained during 
this study was made public and would only be available to the researcher and the cardiologist 
treating the patient.  
 
4.12.4 Safety of the research project 
 
The research is very safe and the procedure that was used is a normal cardiological procedure 
that is used in normal practice for cardiology patients. The use of ultrasound has no adverse 
effect on the body and thus is safe for use on the research patients. 
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Chapter 5 
Results 
 
5.1     Patient demographic data 
 
Hundred-and-fifty patients’ systolic and diastolic variables were measured with 
echocardiography in this study. Hundred-and-twelve of these patients met the inclusion 
criteria. They consisted mainly of asymptomatic follow-up patients who had a history of 
previous heart disease or presented for routine precautionary evaluation due to the presence 
of certain risk factors. Group 1 was recruited as normal controls. 
 
The study group was classified according to age: 20-40 years of age (group 1), 40-60 years of 
age (group 2) and from 60- 80 years of age (group 3) (See Fig. 5.1). Eighty nine percent of 
the patients were male and only 23 % were female. 
 
Fig 5.1   Group distribution according to age  
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Fig 5.2  Gender distribution of the study population according to age 
 
The gender differences were large in all the different age groups. Group 1 has the largest 
male percentage (90.63%) in the study group and group 3 the smallest (71.43%). Marked 
gender differences were present in all groups with males dominant (Fig. 5.2). 
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Table 5.1  Body composition of the study population according to age 
  
Group 1 
 
 
(n=32) 
 
Group 2 
 
 
(n=52) 
 
Group 3 
 
 
(n=28) 
 
Comparison 
between 
groups 
 
p-value 
 
95% CI 
weight (kg) 
mean 
std. 
 
80.2 
(14) 
 
84 
(15) 
 
76 
(12) 
1-2 
 
1-3 
 
2-3 
 
0.195 
 
0.202 
 
0.008 
 
 
 
 
 
0.42;16.6 
 
length (cm) 
mean 
std.  
 
179 
(8.1) 
 
175 
(9.1) 
 
170 
(9.2) 
1-2 
 
1-3 
 
2-3 
 
0.043 
 
0.002 
 
0.020 
 
-0.85;8.7 
 
3.60;14.61 
 
0.06;10.40 
 
BSA (cm2) 
mean 
std. 
 
1.98 
(0.19) 
 
2 
(0.21) 
 
1.9 
(0.17) 
1-2 
 
1-3 
 
2-3 
 
# 
 
# 
 
# 
 
 
 
BMI 
mean 
stdev. 
 
24.9 
(3.4) 
 
27.4 
(3.8) 
 
26.6 
(3.2) 
1-2 
 
1-3 
 
2-3 
 
 
0.003 
 
0.056 
 
0.312 
-4.5;-0.47 
 
-3.79;0.45 
 
# No data available. 
p≤0.05 is significant. 
In Table 5.1 only data with a significant p-value (in yellow), 95% confidence interval values 
were indicated. 
 
Significant differences were present between the groups with regard to weight, height and 
BMI (Table 5.1). A one-way Anova test in table 5.1 represents the whole study population as 
well as the different age groups.  
The average BMI for the total group was 26.58. Group 2 had a higher BMI than the study 
population average. In all three age groups the male population had a higher BMI average 
than the female population.  
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The BMI was divided in 3 categories according to Laquatra (2000) classification for nutrition 
and weight management (Table 5.2). 
 
Table 5.2 BMI and BSA variables in the different age and BMI groups 
 
 
 
 
 Group 
Distribution  
 
n 
 
Average BSA 
(cm2) 
 
Average  
BMI 
 
 
Underweight 
(< 18.50 %) 
 
 
Normal weight 
(18.50-24.99 %) 
 
 
Overweight 
(25.0-30.0%) 
 
 
Obese 
(>30.0%) 
 
Total group 
 
112 1.96 26.58 n=1 (1%) n=43 (38%) n=47 (42%) n=21 (19%) 
     Group 1   
Total 
 
32 1.98 24.9 1 (3%) n=18 (56%) n=10 (31%) n=3 (10%) 
Male 
(91%) 
29 2.02 25.2 0 n=17 (59%) n=9 (31%) n=3 (10%) 
Female 
(9%) 
3 1.6 22.7 1 (34%) n=1 (33%) n=1 (33%) n=1(33%) 
      Group 2   
Total  
 
54 1.99 27.54 0 n=16 (30%) n=24 (44%) n=14 (26%) 
Male 
(78%) 
42 2.07 28.28 0 n=11 (26%) n=18 (43%) n=13 (31%) 
Female 
(22%) 
12 1.71 24.93 0 n=5 (42%) n=5 (50%) n=1 (8%) 
      
 
Group 3   
Total 
 
28 1.88 26.61 0 n=9 (32%) n=14 (50%) n=5 (18%) 
Male 
(71%) 
20 1.96 26.87 0 n=6 (30%) n=10 (50%) n=4 (20%) 
Female 
(29%) 
8 1.68 25.96 0 n=3 (32%) n=4 (50%) n=1 (13%) 
 
Thirty-eight percent of the study population were classified as normal; 56% of group 1, 30% 
in group 2 and 32% in group 3 had a normal weight. Sixty-one percent of the total study 
population were overweight with 41 % in group 1, 70% in group 2 and 68% in group 3. 
Nineteen percent of the total study population were obese (Table 5.2). 
 
BMI CATEGORIES 
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The average body surface area (BSA) for the total study population was 1, 96 cm2.   Group 1 
and 2 were almost similar to the study population average. BSA increased in groups 2 and 3 
(p=0.029). The male population had on average a higher BSA in all 3 age groups. Group 3 
showed a below average BSA with both the male and female groups averages below the 
group average height.  
 
5.2  Left heart dimensions 
 
The left ventricular mass was measured and indexed with the body surface area of the 
patients to determine if left ventricle hypertrophy was present. 
 
Table 5.3 Left heart dimensions according to age and weight 
 
                                       Age groups        BMI categories 
 
 
 
 
 
Group 1 
 
(n=32) 
 
 
Group 2 
 
(n=52) 
 
 
Group 3 
 
(n=28) 
 
 
Normal 
 
(n=44) 
 
 
Overweight 
 
(n=47) 
 
 
Obese 
 
(n=21) 
LV mass (g) 
mean 
std. 
 
206 
(58.18) 
 
240 
(71.90) 
 
253 
(81.44) 
 
216 
(62.02) 
 
247 
(79.74) 
 
244 
(79.68) 
LV Mass Index (g/cm2) 
mean 
std. 
 
100 
(23.66) 
 
120 
(32.14) 
 
130 
(35.30) 
 
106 
(25.76) 
 
122 
(34.65) 
 
130 
(36.82) 
LV Internal dimension diastole(mm) 
mean 
std. 
 
51 
(4.23) 
 
50 
(6.76) 
 
48 
(6.42) 
 
52 
(4.88) 
 
49 
(6.27) 
 
 
 
49 
(6.50) 
 
 
LV Internal dimension systole(mm) 
mean 
std. 
 
32 
(3.64) 
 
32 
(6.08) 
 
30 
(5.98) 
 
32 
(4.48) 
 
31 
(5.68) 
 
30 
(5.81) 
Relative wall thickness (%)  
mean 
std. 
 
0.40 
(0.08) 
 
0.45 
(0.12) 
 
0.5 
(0.13) 
 
0.39 
(0.07) 
 
0.47 
(0.13) 
 
0.49 
(0.03) 
Left atrium internal dimension(mm) 
mean 
std. 
 
34 
(7.20) 
 
37 
(7.71) 
 
40 
(4.89) 
 
34 
(6.97) 
 
37 
(7.56) 
 
40 
(5.35) 
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5.2.1  Muscle thickness 
 
Table 5.3 shows a 26% increase in mass index from the normal weight group to the obese 
group. The left ventricle mass increased with ageing (p=0.029) with the most significant 
changes observed between group 1 and group 3 (p<0.005). With regards to left ventricle mass 
index, the largest difference  were observed between group 1 and group 3 (p<0.001). 
 
5.2.2 Left ventricle internal dimensions 
   
Changes occurred in the internal dimension of systole and diastole with ageing. There was a 
5.9 % decrease in the diastolic dimension of the left ventricle with ageing and a 6, 25% 
decrease in the systolic internal dimension of the left ventricle. Internal dimension was 
compared according to the BMI categories and no difference were detected (Table 5.3). A 
5,8% decrease in internal diastolic dimension and a decrease of only 3,1 % for the systolic 
dimension were observed (Table 5.3).  
 
5.2.3  Relative wall thickness 
 
The relative wall thickness increased with 28% during ageing from group 1 to group 3 (Table 
5.3). Significant differences were detected in the relative wall thickness between the different 
age groups:  between group 1 and 2 (p=0.011), group 2 and 3 (p=0.101) and group 1 and 
group 3 (p=0.001). When the relative wall thickness is compared according to the BMI 
categories almost the same scenario is demonstrated (Table 5.3). The obese group showed a 
26 % change in relative wall thickness from the normal weight group to the obese group 
(p=0.331). 
 
5.2.4 Left atrium 
 
In Table 5.3 the LA size increased 18% with ageing (p=0.007).  The mean value for atrial 
size for the whole study population was 37 mm with only group 3 above study average (40 
mm). Differences were significant for group 1 and 3 (p=0.001) and between group 2 and 3 
(p=0.022) but not for group 1 and 2 (p=0.139). 
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5.3  Hemodynamic variables 
 
Hemodynamic variables of the study population are indicated in Table 5.4. 
 
Table 5.4 Mean hemodynamic variables for the study population (n=112) 
                        
                            
 
n 
 
Heart rate 
 
 
(Bpm) 
 
Stroke volume 
 
 
(ml) 
 
 
 
 
Stroke volume 
index 
 
(ml/cm2) 
 
 
 
Cardiac output 
 
 
(l/min) 
 
 
 
 
Cardiac output 
index 
 
(l/min/cm2) 
Total  
group               
 
mean 
std. 
 
112  
 
 
71 
(12.47) 
 
 
 
 
104 
(22.53) 
 
 
 
53 
(11.90) 
 
 
 
7.4 
(1.85) 
 
 
 
3.8 
(1.01) 
Group 1                               
 
mean  
std. 
 
32  
 
69 
(12.44) 
 
 
95 
(29.47) 
 
 
48 
(9.05) 
 
 
6.6 
(1.98) 
 
 
3.3 
(0.83) 
Group 2                                 
                              
mean 
std. 
52  
 
72 
(13.01) 
 
 
107 
(23.00) 
 
 
54 
(12.28) 
 
 
7.7 
(1.67) 
 
 
3.9 
(0.95) 
 
Group 3                               
 
 
mean 
std. 
 
28
 
 
 
 
68 
(12.23) 
 
 
 
 
110 
(22.15) 
 
 
 
 
59 
(12.56) 
 
 
 
 
7.5 
(1.80) 
 
 
 
 
4.0 
(1.02) 
 
The mean heart rate of the study population was 71 beats per minute and it more or less 
remained the same with ageing (p=0.230). As illustrated in Table 5.4, the stroke volume 
(p=0.019) and stroke volume index (p=0.002), the cardiac output (p=0.008) and the cardiac 
output index (p=0.001) demonstrated an increased value with ageing.  The average cardiac 
output of group 3 was less than group 2, but correlated with a lower stroke volume in that 
group as well. Only group 1 showed a lower value than the study population average. 
 
The stroke volume between groups 1 and 2 increased significantly (p=0.012) as well as 
between groups 1 and 3 (p=0.011) (Table 5.4). Differences in stroke volume index between 
group 1 and 2 (p= 0.011), group 1 and 3 (p=0.004) and group 2 and 3 (p=0.093) were present. 
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The cardiac output indexed to BSA increased significantly between group 1 and 2 (p=0.007) 
and group 1 and 3 (p=005) but no significance difference was detected between group 2 and 3 
(p=0.463). 
 
5.4 Systolic data 
 
All relevant data for systolic variables can be viewed in Table 5.5. 
 
Table 5.5 Systolic measurements of the left ventricle 
  
n 
 
Ejection 
fraction 
 
(%) 
 
Shortening 
fraction 
 
(%) 
 
Ejection 
time 
 
(m/s) 
 
Mean circumferential 
shortening 
 
(circ/s) 
 
S’ septum 
 
 
(cm/s) 
 
S’ lateral 
 
 
(cm/s) 
Total 
group 
 
 
mean 
std. 
112  
 
 
67 
(7.88) 
 
 
 
 
37 
(6.05) 
 
 
 
283  
(23.09) 
 
 
 
1.3 
(0.23) 
 
 
 
8.5 
(1.53) 
 
 
 
 
10 
(2.35) 
group 1  
 
 
mean 
std. 
32  
 
 
68 
(5.60) 
 
 
 
 
38 
(4.42) 
 
 
 
272  
(18.83) 
 
 
 
1.4 
(0.16) 
 
 
 
9.5 
(1.65) 
 
 
 
12 
(2.1) 
group 2 
 
 
mean 
std. 
52  
 
 
66 
(8.38) 
 
 
 
 
37 
(6.34) 
 
 
 
283  
(26.02) 
 
 
 
1.3 
(0.26) 
 
 
 
8.4 
(1.43) 
 
 
 
10 
(2.08) 
group 3 
 
 
mean 
std. 
28  
 
 
68 
(9.51) 
 
 
 
38 
(7.36) 
 
 
 
294  
(25.93) 
 
 
 
1.3 
(0.27) 
 
 
 
7.9 
(1.24) 
 
 
 
9 
(2.02) 
  
The ejection fraction (p=0.527), shortening fraction (p= 0.594) and the mean circumferential 
shortening (p=0.279) did not change significantly with ageing (Table 5.5). With ageing the 
ejection time prolonged but not always significant between group 1 and 2 (p=0.138), group 1 
and 3 (p=0.003) and between group 2 and 3 (p=0.074).  
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The systolic prime (S’) of the tissue velocity of the septum (p<0.001) and the lateral wall 
(p<0.001) also decreased with ageing. S’ septum (p<0.001) and S’ lateral (p<0.001) 
demonstrated a decrease between group 1 and group 3. Between group 2 and 3 no 
significance (p=0.061) was detected in the S’ of the septum, although the S’ lateral of the 
same groups did show significant decrease (p=0.0103) (Table 5.5). The Tei index 
demonstrated normal values in all the groups but was lower in the overweight subjects of 
group 1 (p=0.040). Also, a significant lower value of the Tei index were found in group 3 
with ischemic risk factors versus those without ischemia (p=0.010). Subjects in group 2 with 
diabetes had a significantly lower Tei index compared to those without diabetes (p=0.040). 
 
5.5  Diastolic data 
 
The trans-mitral E peak showed a decline with ageing (p=0.001). The A peak increased with 
ageing (p<0.001). The ratio measurement between the groups also decreased in value with 
ageing (See Table 5.6). 
 
The isovolumetric relaxation time increased significantly (p=0.009) with ageing (group 1 to 
3) as well as the deceleration time of the left ventricle (p=0.001). The ratios of the E and A 
peaks also changed with ageing (p<0.001) (Table 5.6). 
 
Muscle velocity measurements were not affected by volume loading of the left ventricle. A 
decrease in the velocity of the E’ of the septal aspects (p<0.001), as well as the lateral aspects 
(p<0.001) of the annulus, was detected. The A’ showed a significant increase in velocity over 
the septal (p=0.004) and lateral annulus (p=0.001) (Table 5.6).  
 
The E’/A’ ratio of the septum decreased with ageing (p=0.043) and a significant decrease in 
ratio were apparent on the lateral wall (p<0.001).  
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Table 5.6 Diastolic data according to age and BMI categories. 
   
  The p- values between the different age groups are illustrated in Table 5.7 
 
In Table 5.6 diastolic measurements mean values, associated with different BMI groups are 
illustrated. 
The E peak decreased with increased BMI although there was a small increase from group 2 
in the obese group. The A peaks also increased with abnormal BMI as it did with ageing. The 
deceleration time and isovolumetric relaxation time increased with increased BMI even more 
compared to ageing. The measurements of tissue Doppler between the BMI groups showed a 
similar profile as with ageing, but the E’ lateral velocity decreased more with advancing BMI 
than with age (Table 5.6). 
                   Age groups 
 
                  BMI categories 
  
Variables with 
 
Mean and 
Std. 
 
 Total 
study 
group 
 
(n=112) 
Group 1 
 
 
 
(n=32) 
Group 2 
 
 
 
(n=52) 
Group 3 
 
 
 
(n=28) 
Normal 
weight 
 
 
(n=43) 
Over-
weight 
 
 
(n=46) 
Obese 
 
 
 
(n=23) 
E   
(cm/s) 
 73 
(17.00) 
83 
(15.95) 
70 
(16.66) 
68 
(14.69) 
80 
(15.76) 
67 
(16.86) 
 
70 
14.54) 
A  
(cm/s) 
 64 
(18.00) 
47 
(11.14) 
65 
(12.72) 
80 
(16.03) 
52 
(15.76) 
65 
(16.86) 
84 
(14.55) 
E/A  1.3 
(0.52) 
1.8 
(0.52) 
1.1 
(0.33) 
 
0.9 
(0.16) 
1.6 
(0.55) 
1.1 
(0.33) 
0.8 
(0.15) 
 
IVRT  
(ms) 
 100 
(21.00) 
92 
(18.29) 
101 
(22.36) 
107 
(18.40) 
173 
(18.63) 
193 
(21.67) 
238 
(20.48) 
DT  
(ms) 
 195 
(56.63) 
171 
(31.71) 
189 
(47.03) 
 
233 
(74.05) 
94 
(32.50) 
102 
(50.40) 
109 
(81.92) 
E’ Septum 
(cm/s) 
 10 
(3.02) 
13 
(2.25) 
9 
(2.13) 
7 
(1.43) 
12 
(2.60) 
8 
(2.20) 
7 
(1,37) 
A’ Septum 
(cm/s) 
 10 
(2.22) 
9 
(2.01) 
11 
(2.31) 
11 
(1.66) 
9 
(2.17) 
11 
(2.19) 
11 
(1.65) 
E’/A’ 
Septum 
 
 1.1 
(1.22) 
1.5 
(0.41) 
1 
(1.71) 
0.7 
(0.17) 
1.3 
(0.44) 
1 
(1.80) 
0.7 
(0.14) 
E’ Lateral 
(cm/s) 
 13 
(4.44) 
18 
(3.88) 
12 
(2.70) 
11 
(2.93) 
16 
(4.02) 
11 
(3.03) 
9 
(2.92) 
A’ Lateral 
(cm/s) 
 12 
(3.00) 
9 
(2.50) 
12 
(2.82) 
13 
(2.33) 
10 
(2.65) 
12 
(2.98) 
13 
(2.12) 
E’/A’ Lateral 
 
 1.2 
(0.70) 
2 
(0.74) 
1 
(0.34) 
0.8 
(0.24) 
1.7 
(0.75) 
1 
(0.35) 
0.7 
(0.24) 
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The p-values between the different age groups are illustrated in Table 5.7. 
 
Table 5.7 t-test comparison between the groups of the diastolic data 
  
t-test comparison between groups for diastolic data 
  
group 1 group 2 group 3 
    <0.01 * 
E   <0.01   * 
 >0.05   
   <0.001 * 
A    <0.001   * 
 <0.001   * 
   <0.001 * 
E/A    <0.001   * 
 <0.01   * 
   >0.05 
IVRT    <0.05   * 
 >0.05   
   >0.05 
DT    <0.001   * 
 <0.001   * 
   <0.001 * 
E’ Septum    <0.001   * 
 <0.01   * 
   <0.01 * 
A’ Septum    <0.05   * 
 <0.05   
   >0.05 
E’/A’ Septum    <0.05   * 
 >0.05   
   <0.001 * 
E’ Lateral    <0.001   * 
< 0.01   * 
   <0.001 * 
A’ Lateral    <0.001   * 
 >0.05   
   <0.001 * 
E’/A’ Lateral    <0.001   * 
 >0.05   
*Significant p-values 
p=value between group 1 and group 2 
p=value between group 1 and group 3 
p=value between  group 2 and group 3 
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Fig. 5.3  Percentage differences of diastolic variables between ageing and BMI 
categories. 
 
In Fig. 5.3 the differences in diastolic measurements were compared with the BMI and the 
age groups. A prominent change on the diastolic variables was detected on the A’ lateral TDI. 
The A peak of the trans-mitral inflow also differed between the groups. From the E/A ratios 
the E’/A’ of the septum showed the largest percentage difference amongst the two groups. 
The E’ lateral velocity showed a 44% decrease from the normal weight group to the obese 
group and a 39% change from the younger group to the older group. Age appears to have a 
greater effect on the lateral E’ parameter than the BMI (Fig. 5.3). 
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5.6  Clinical risk factors 
 
Table 5.8 indicates the incidence of risk factors between the different age groups. The most 
prevalent risk factors are highlighted in red. 
 
Table 5.8 Incidence of risk factors among the age groups 
                  Group 1  
(n=32) 
Group  2  
(n=52) 
Group 3 
 (n=28) 
Alcohol   
(n=29) 
17(53%) 11(21%) 1(4%) 
Smokers 
(n=42) 
21(65%) 15(29%) 6(21%) 
Overweight 
(n=70) 
13(41%) 38(71%) 19(71%) 
Hypertension 
(n=47) 
2(6%) 24(46%) 21(75%) 
Cholesterol 
(n=36) 
2(6%) 27(52%) 7(25%) 
Ischemia 
(n=42) 
0(0%) 21(40%) 21(75%) 
Diabetes 
(n=7) 
0(0%) 4(8%) 3(11%) 
 
According to Table 5.8 it appears that obesity was the most dominant risk factor observed 
between the age groups. Group 2 and 3 had all the risk factors associated with them but group 
1 did not have ischemia or diabetes as a risk factor. Group 2 had the most risk factors of all 
the groups.  
 
5.6.1 Group 1  
 
Fig. 5.4 represents the frequency of combinations of different risk factors. Each colour 
represents the number patients per combination of risk factors. For instance, in patients who 
only had one risk factor (blue bar), cholesterol was found in only one, two were overweight, 
four were smokers and three were alcohol consumers. In patients who had 2 risk factors 
(green bar), one was overweight, seven were smokers and six consumed alcohol. The group 
with a combination of three risk factors (red bar) nine were overweight, nine were smoking 
and seven consumed alcohol. With a combination of four risk factors (black bar) only one 
smoked, one had high cholesterol, one consumed alcohol and one was overweight. 
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Fig 5.4  Frequency of risk factor combination in group 1 
 
 
5.6.2  Group 2  
 
Group 2 had the most combinations and also the highest frequency of risk factors in 
comparison to the other groups. With a combination of 3 risk factors, having cholesterol and 
being overweight had the highest frequency. In the combination of 4 risk factors, being 
overweight was the most common risk factor, with ischemia and hypertension also very 
prominent. Groups with 5 risk factors had all the risks associated with them. Only one patient 
had six risk factors associated with him. Cholesterol and being overweight had the highest 
frequency in this age group (Fig. 5.5). 
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Fig 5.5  Frequency of risk factor combination in group 2 
 
 
5.6.3 Group 3 
 
In this age group the patients with only one risk factor were divided between ischemia and 
being overweight. The most frequent risk factor of being overweight occurred in the patients 
with a combination of four risk factors.  Other prevalent risk factors in this group were 
hypertension, cholesterol and ischemia (Fig. 5.6). 
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Fig. 5.6 Frequency of risk factor combination in group 3 
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5.7  Clinical risk factors 
 
Table 5.9 Diastolic variables for overweight as risk factor  
 
 
 
Normal weight 
Overweight 
Group  1 
(n=19) 
(n=13) 
Group 2 
(n=15) 
(n=37) 
Group 3 
(n=8) 
(n=20) 
  mean (std) mean (std) mean (std) 
RWT Normal weight 
 
0.38 (0.05) 0.43 (0.08) 0.51 (0.14) 
 Overweight 0.41(0.11) 0.46 (0.13) 0.49 (0.12) 
Mass 
(g) 
Normal weight  
 
189.84 (34.73) 218 (72.70) 229.13 (69.76) 
 Overweight 230.46 (76.64) 248.93 (70.76) 262.85 (85.38) 
Mass Index 
(g/cm2) 
Normal weight 
 
98.84 (15.24) 114.67 (32.07) 123.38 (34.31) 
 Overweight 109.31 (32.06 119.35 (32.51) 136.05 (35.89) 
E 
(cm/s) 
Normal weight 
 
80.58(16.60) 74.26 (16.09) 64.75 (14.09) 
 Overweight 85.85 (15.02) 68.65 (16.83) 68.8 (15.11) 
A 
(cm/s) 
Normal weight 
 
42.74 (9.44) 59.66 (12.35) 78.62 (13.16) 
 Overweight 54.23 (9.71) 65.83 (12.59) 81.15 (17.30) 
E/A ratio Normal weight 
 
1.96 (0.59) 1.28 (0.35) 0.83 (0.14) 
 Overweight 1.60 (0.30) 1.07 (0.30) 0.86 (0.17) 
E'/A' ratio sep Normal weight 
 
1.59 (0.47) 1.76 (3.12) 0.70 (0.16) 
 Overweight 1.27 (0.21) 0.76 (0.21) 0.67 (0.17) 
E'A' ratio lat Normal weight 
 
2.22 (0.81) 1.2 (0.40) 0.88 (0.31) 
 Overweight 1.62 (0.45) 0.94 (0.27) 0.71 (0.18) 
S' sep 
(cm/s) 
Normal weight 
 
9.26 (1.41) 8.43 (1.64) 8.37 91.06) 
 Overweight 9.85 (1.95) 8.43 (1.36) 7.65 (1.26) 
S' lat 
(cm/s) 
Normal weight 
 
11.37 (1.95) 10.13 (2.35) 9.62 (3.11) 
 Overweight 11.77 (2.39) 10.32 (1.98) 8.75 (1.40) 
TEI Normal weight 
 
0.43 (0.13) 0.45 (0.09) 0.45 (0.09) 
 Overweight 0.34 (0.09) 0.43 (0.13) 0.44 (0.16) 
 
Measurement of the diastolic variables in group 1 with overweight risk factor revealed 
significant changes occurred in the trans-mitral A wave (p=003) 95% confidence interval(CI) 
(-18.63;-4.36), E/A ratio (p=0.030)95% CI(-0.01;0.72), E’/A’ ratio septum (p=0.013) 95% 
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CI(0.04;0.60),E’/A’ ratio lateral (p=0.013) 95%CI (0.08;1.11), S’ lateral (p=0.030) 95% CI (-
1.97;1.17) and the Tei index (p=0.040) 95% CI (0.01;0.17). 
 
Group 2 only revealed significant change in the E’/A’ lateral (p=0.027) 95% CI (0.08; 0.47). 
No changes occurred in group 3. 
 
Table 5.10  Diastolic variables for hypertension as risk factor 
 
 
Not Hypertensive 
Hypertensive 
  
Group 1 
(n=30) 
(n=2) 
 
 
Group 2 
(n=28) 
(n=24) 
 
Group 3 
(n=7) 
(n=21) 
  mean (std) mean (std) mean (std) 
RWT Not hypertensive 0.38 (0.06) 0.44 (0.08) 0.50 (0.13) 
 Hypertensive 0.53(0.18) 0.46 (0.15) 0.49 (0.12) 
Mass 
(g) 
Not hypertensive 202.9 (52.53) 230.18 (61) 272.29 (94.21) 
 Hypertensive 258 (138) 251.54 (82.70) 246.86 (78.24) 
Mass Index 
(cm/g) 
Not hypertensive 101.93 (19.46) 114.25 (26.02) 134.71 (39.79) 
 Hypertensive 120.5 (75.66) 122.38 (38.19) 131.67 (34.79) 
E 
(cm/s) 
Not hypertensive 82.43 (16.39) 69.71 (17.53) 72.71 (14.44) 
 Hypertensive 87 (7.07) 70.91(15.94) 65.95 (14.72) 
A 
(cm/s) 
Not hypertensive 46.8 (11.18) 60.68 (10.08) 84.43 (13.06) 
 Hypertensive 56.5(6.3) 68 (14.46) 79.09 (16.97) 
E/A ratio Not hypertensive 1.84 (0.53) 1.17 (0.31) 0.87 (0.14) 
 Hypertensive 1.53(0.06) 1.08 (0.35) 0.84 (0.17) 
E'/A' ratio sep Not hypertensive 1,48 (0.42) 1.30 (2.30) 0.65 (0.18) 
 Hypertensive 1.15 (0.32) 0.78 (0.30) 0.68 (0.17) 
E'A' ratio lat Not hypertensive 2.00 (0.76) 1.10 (0.36) 0.69 (0.10) 
 Hypertensive 1.52 (0.32) 0.92 (0.27) 0.78 (0.26) 
S' sep 
(cm/s) 
Not hypertensive 9.53 (1.5) 8.46 (1.37) 7.71(0.75) 
 Hypertensive 9 (9.24) 8.41(1.52) 7.90 (1.37) 
S' lat 
(cm/s) 
Not hypertensive 11.57 (2.16 ) 10.28 (2.17) 8.00 (1.30) 
 Hypertensive 11 (1.41) 10.25 (2.00) 9.3 (2.12) 
TEI Not hypertensive 0.39 (0.12) 0.45 (0.11) 0.50 (0.10) 
 Hypertensive 0.38 (0.20) 0.43 (0.14) 0.42 (0.15) 
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Diastolic variables related to the hypertension risk group revealed increase in group 1 in 
RWT (p=0.008) 95% CI (-1.12; 2.18), the E/A ratio (p=0.011) 95% CI (-0.47; 1.09) and the 
E’/A’ ratio of the septum (p=0.004) 95% CI (-0.28; 0.94). 
Group 2 demonstrated increase in the trans-mitral A peak (p= 0.044) 95%CI (-14.19; 0.45) 
and E’/A’ lateral (p=0.032) 95%CI (-0.02; 0.37). No changes occurred in group 3. 
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Table 5.11 Diastolic variables for smoking risk factor 
 
 
 
Non-smokers 
Smokers 
  
Group 1 
 
(n=11) 
(n=21) 
 
mean (std)                                         
 
Group 2 
 
(n=37) 
(n=15) 
 
mean (std) 
 
Group 3 
 
(n=22) 
(n=6) 
 
mean (std)  
RWT Non-smokers 
 
0.36 (0.05) 0.47 (0.12) 0.51 (0.12)            
 Smokers 0.41 (0.09) 0.39 (0.06) 0.45 (0.11) 
Mass 
(g) 
Non-smokers 
 
199 (32.77) 248.38 (71.33) 246.32 (74.60) 
 Smokers 210.09 (68.29) 219.47 (71.49) 278.50 (107.07) 
Mass index 
(g/cm2) 
Non-smokers 
 
102.27 (13.43) 122 (32.38) 131.09 (34.08) 
 Smokers 103.52(27.87) 108.13 (30.34) 137.33 (42.58) 
E 
(cm/s) 
Non-smokers 
 
86.81(17.78) 71.67(13.67) 67.86 (15.76) 
 Smokers 80.57 (14.89) 66.8(11.95) 66.83 (10.98) 
A 
(cm/s) 
Non-smokers 
 
47.18 (10.04) 65.43 (10.23) 82.31(17.36) 
 Smokers 47.52 (11.91) 60.66 (12.84) 73.50 (6.94) 
E/A ratio Non-smokers 
 
1.92 (0.63) 1.12 (0.31) 0.83 (0.16) 
 Smokers 1.76 (0.45) 1.13 (0.37) 0.91 (0.15) 
E'/A' ratio sep Non-smokers 
 
1.45 (0.39) 1.10 (2.02) 0.69 (0.16) 
 Smokers 1.46 (O.42) 0.92 (0.29) 0.60 (0.17) 
E'A' ratio lat Non-smokers 
 
2.09 (0.90) 0.97 (0.34) 0.75 (0.25) 
 Smokers 1.91 (0.65) 1.14 (0.31) 0.77 (0.16) 
S' sep 
(cm/s) 
Non-smokers 
 
9.09 (1.57) 8.51 (1.32) 7.77 (1.30) 
 Smokers 9.91 (1.67) 8.26 (1.70) 8.16 (0.98) 
S' lat 
(cm/s) 
Non-smokers 
 
11.00 (2.09) 10.45 (2.29) 9.09 (2.06) 
 Smokers 11.81 (2.11) 9.8 (1.37) 8.66(1.96) 
TEI Non-smokers 
 
0.37 (0.14) 0.43 (0.12) 0.43 (0.12) 
 Smokers 0.40(0.11) 0.46 (0.12) 0.48 (0.21) 
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The A peak velocities were significantly affected in group 2 with smoking as risk factor 
(p=0.004) 95 CI (-3.02; 12.55). No variables in any of the other groups revealed any 
significant abnormalities. 
 
Table 5.12 Diastolic variables for cholesterol risk factor 
  Group 1 Group 2 Group 3 
No Cholesterol 
Hyperlipidemia 
 (n=30) 
(n=2) 
mean (std) 
 (n=25) 
(n=27) 
mean (std) 
 (n=21) 
(n=7) 
mean (std) 
RWT No Cholesterol 0.39(0.08) 0.44 (0.13) 0.48 (0.13) 
 Hyperlipidemia 0.35 (0.07) 0.45 (0.09) 0.53 (0.09) 
Mass 
(g) 
No Cholesterol 205.30 (95.52) 257.40 (80.42) 249.00 (88.27) 
 Hyperlipidemia 218.5 (43.13) 223.96 (60.10) 265.86(60.19) 
Mass Index 
(g/cm2) 
No Cholesterol 103.03(24.32) 126.96 (38.10) 129.43 (37.56) 
 Hyperlipidemia 104.00(14.14) 109.7 (23.19) 141.43 (27.86) 
E 
(cm/s) 
No Cholesterol 83.63(14.98) 71.68 (17.35) 68.09 (15.84) 
 Hyperlipidemia 69.00(31.11) 68.96 (16.22) 66.28(11.45) 
A 
(cm/s) 
No Cholesterol 47.53 (11.5) 67.92 (11.46) 82.04 (17.57) 
 Hyperlipidemia 45.5(2.12) 60.48 (12.98) 75.57 (9.50) 
E/A ratio No Cholesterol 1.83 (0.51) 1.08 (0.31) 0.83 (0.14) 
 Hyperlipidemia 1.54 (0.76) 1.17 (0.34) 0.89 (0.20) 
E'/A' ratio sep No Cholesterol 1.48 (0.40) 0.78 (0.23) 0.65 (0.15) 
 Hyperlipidemia 1.12 (0.53) 1.30 (2.35) 0.74 (0.19) 
E'A' ratio lat No Cholesterol 2.01 (0.74) 0.95 (0.23) 0.75 (0.24) 
 Hyperlipidemia 1.45 (0.63) 1.08 (0.40) 0.76 (0.22) 
S' sep 
(cm/s) 
No Cholesterol 9.5 (1.69) 8.64 (1.22) 8.04 (1.16) 
 Hyperlipidemia 9.5 (0.70) 8.25 (1.60) 7.28 (1.38) 
S' lat 
(cm/s) 
No Cholesterol 11.56 (2.16) 10.52 (1.93) 8.90 (2.18) 
 Hyperlipidemia 11.00 (1.41) 10.03 (2.20) 9.28 (1.49) 
TEI 
 
No Cholesterol 0.38 (0.10) 0.42 (0.09) 0.46( 0.14) 
 Hyperlipidemia 0.54 (0.26) 0.45 (0.13) 0.39(0.12) 
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The A peak velocity of the trans-mitral flow showed significant decrease in group 2 that had 
high cholesterol (p=0.031) 95% CI (0.60; 14.28). No other variable in any other groups 
showed any abnormality (Table 5.12). 
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Table 5.13 Diastolic variables for ischemia as risk factor 
 
 
Non-ischemic  
Ischemia  
  
Group 1 
 ( n=0) 
 ( n=0) 
 
 
Group 2 
(n=31) 
(n=21) 
 
Group 3 
(n=7) 
(n=21) 
  mean (std) mean (std) mean (std) 
RWT Non-ischemic  
 
# 0.46 (0.13) 0.44 (0.10) 
 Ischemia # 0.44 (0.09) 0.51 (0.12) 
Mass 
(g) 
Non-ischemic  
 
# 229.77 (71.91) 253.71 (74.83) 
 Ischemia # 255.19 (70.86) 253.05 (85.29) 
Mass Index 
(g/cm2) 
Non-ischemic  
 
# 113.61 (32.87) 133.57 (76.93) 
 Ischemia # 124.48 (30.65) 132.05 (38.25) 
E 
(cm/s) 
Non-ischemic  
 
# 71.35 (15.36) 67.28 (15.81) 
 Ischemia # 68.66 (18.69) 67.76 (14.70) 
A 
(cm/s) 
Non-ischemic  
 
# 63.48 (12.27) 84.85 (19.16) 
 Ischemia # 64.90 (13.61) 78.95 (15.08) 
E/A ratio Non-ischemic  
 
# 1.15 (0.30) 0.80 (0.17) 
 Ischemia # 1.09 (0.37) 0.86 (0.15) 
E'/A' ratio sep Non-ischemic  
 
# 0.82 (0.27) 0.59 (0.17) 
 Ischemia # 1.40(2.66) 0.70 (0.16) 
E'A'  ratio lat Non-ischemic  
 
# 1.01 (0.26) 0.63 (0.23) 
 Ischemia # 1.02 (0.43) 0.80(0.22) 
S' sep 
(cm/s) 
Non-ischemic  
 
# 8.74 (1.31) 8.14 (0.89) 
 Ischemia # 8.00 (1.51) 7.76 (1.33) 
S' lat 
(cm/s) 
Non-ischemic  
 
# 10.54 (2.06) 8.71 (2.21) 
 Ischemia # 9.85 (2.08) 9.09(1.99) 
TEI Non-ischemic  
 
# 0.45 (0.12) 0.35 (0.07) 
 Ischemia # 0.41 (0.11) 0.47 0.15) 
# No data available 
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Only the Tei index in group 3 increased in the ischemia group (p=0.012) 95% CI (-0.24; 
0.01). No other variables demonstrated abnormalities. 
 
Table 5.14 Diastolic variables for diabetes as risk factor 
  Group 1 Group 2 Group 3 
 
Not diabetic 
Diabetic 
 n=32 
n=0 
mean (std) 
n=48 
n=4 
mean (std) 
n=25 
n=3 
mean (std) 
RWT Not diabetic # 0.45 (0.12) 0.49 (0.12) 
 Diabetic # 0.43 (0.02) 0.52 (0.12)) 
Mass 
(g) 
Not diabetic # 235.65 (64.45) 244.48 (77.89) 
 Diabetic # 292.75(137.08) 326 (88.47) 
Mass Index 
(g/cm2) 
Not diabetic # 116.02 (29.20) 128.52 (33.74) 
 Diabetic # 141.75 (58.23) 165 (37.04) 
E 
(cm/s) 
Not diabetic # 70.81 (16.82) 68.08 (15.16) 
 Diabetic # 63.75 (15.04) 64.00 (11.53) 
A Not diabetic # 63.89 (12.69) 80.92 (16.53) 
 Diabetic # 66.00 (14.9) 76.33(12.66) 
E/A ratio Not diabetic # 1.14 (0.32) 0.85 (0.16) 
 Diabetic # 1.02 (0.39) 0.83 (0.09) 
E'/A' ratio sep Not diabetic # 1.08 (1.77) 0.68(0.17) 
 Diabetic # 0.71 (0.29) 0.61(0.13) 
E'A' ratio lat Not diabetic # 1.04 (0.33) 0.77 (0.24) 
 Diabetic # 0.78 (0.43) 0.65 (0.13) 
S' sep Not diabetic # 8.41 (1.38) 7.84 (1.21) 
 Diabetic # 8.75 (2.21) 8.00(1.73) 
S' lat Not diabetic # 10.25 (2.09) 8.97 (2.13) 
 YES # 10.50 (2.08) 9.33(0.57) 
TEI Not diabetic # 0.44 (0.12) 0.43 (0.13) 
 Diabetic # 0.37 (0.05) 0.54 (0.23) 
 
The diabetic risk factor group only revealed decreases in the Tei index of group 2 (p=0.040). 
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Table 5.15 Diastolic variables for alcohol as risk factor 
  
No alcohol 
Alcohol user 
Group 1 
 (n=15) 
 (n=17) 
 
Mean (std) 
Group 2 
(n=41) 
(n=11) 
 
Mean (std) 
Group 3 
      (n=0) 
      (n=0) 
 
Mean (std) 
RWT No alcohol 0.39 (0.08) 0.45 (0.12) # 
 Alcohol user 0.39  (0.07) 0.43 (0.09) # 
Mass No alcohol 203.33 (52.13) 244.66 (72.86) # 
 Alcohol user 209.00 (64.52) 222.82 (68.66) # 
Mass Index No alcohol 103.47 (24.67) 120.44 (33.18) # 
 Alcohol user 102.76 (23.49) 108.91 (27.39) # 
E No alcohol 80.06(16.84) 70.92 (17.51) # 
 Alcohol user 85.05(15.23) 67.81 (13.43) # 
A No alcohol 44.4 (9.70) 66.12 (11.85) # 
 Alcohol user 50.05 (11.92) 56.36 (13.42) # 
E/A ratio No alcohol 1.87 (0.58) 1.10 (0.35) # 
 Alcohol user 1.76(0.47) 1.21 (0.19) # 
E'/A' ratio sep No alcohol 1.49 (0.48) 1.10 (1.92) # 
 Alcohol user 1.43 (0.35) 0.85 (0.19) # 
E'/A' ratio lat No alcohol 1.97 (0.90) 0.98 (0.34) # 
 Alcohol user 1.97 (0.58) 1.16 (0.27) # 
S' sep No alcohol 8.86 (1.64) 8.41 (1.44) # 
 Alcohol user 10.05 (1.47) 8.54 (1.43) # 
S' lat No alcohol 10.53 (1.55) 10.09 (2.05) # 
 Alcohol user 12.41 (2.18) 10.90 (2.11) # 
TEI No alcohol 0.42 (0.13) 0.44 (0.13) # 
 Alcohol user 0.36 (0.10) 0.43 (0.08) # 
#  No data available 
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Chapter 6 
Discussion 
 
Echocardiography and especially Doppler echocardiography are routinely used in cardiology 
practices. Clinically it is important to determine left ventricular diastolic function because of 
the role it plays in the evaluation of heart failure and the treatment of patients with isolated 
diastolic dysfunction. Trans- mitral flow velocity patterns obtained by pulsed Doppler 
echocardiography are widely used to evaluate global left ventricle diastolic function. These 
trans-mitral flow measurements are limited because patients with elevated global left 
ventricular end diastolic pressure may have a pseudo-normal flow pattern. This is why the 
newer method of tissue Doppler imaging was used in addition to trans-mitral flow to evaluate 
the diastolic properties of the study group.  Left ventricular diastolic filling and systolic 
variables can be determined reliably by using these techniques. Diastolic filling abnormalities 
are broadly classified as either impaired relaxation or restrictive physiology (Yamada et al., 
2002). Diastolic dysfunction is increasingly recognised as having an important influence on 
symptoms and hemodynamic status of the heart.  
Diastole extends from aortic valve closure to mitral valve closure in four distinct phases. 
 Isovolumetric relaxation represents the time from aorta closure till just before the 
mitral valve opens. 
 Early filling accounting for up to 80% of the total ventricular filling.  
 Diastasis represents the time when the left atrial and left ventricular pressures equalise 
and no flow occurs. 
 Atrial systole accounting for the remainder of the ventricular filling.  
Clinically it is important to evaluate the left ventricle diastolic function non-invasively and 
accurately. Left ventricle diastolic function and in particular left ventricular relaxation 
becomes impaired with age, even in the healthy population. This study’s purpose was to 
measure the effect clinical variables have on these diastolic and systolic variables, as well as 
to evaluate the effects ageing has on diastolic variables.  
 
The effects of ageing on the diastolic and systolic variables were evaluated with the use of 
pulse wave Doppler imaging. The major finding was that obesity poses a very big problem 
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and this risk factor had the most profound effect on the systolic and diastolic variables in this 
study. The results of this study suggest that it is important to include measurements of 
diastolic variables when using echocardiography during daily practice. Another observation 
of the study was that systolic variables did not change that much although diastolic variables 
did show abnormalities with age and with obesity. Sixty one percent of the study population 
was overweight with 19% being obese. Group 1 consisted of 41% overweight subjects, group 
2 seventy percent and group 3 sixty eight percent (Fig 5.2). This study demonstrated that the 
measurement of systolic variables is not adequate to evaluate asymptomatic patients 
presenting at a general cardiology practice. Systolic variables showed little change but most 
of the diastolic variables changed. It also showed that changes occur with ageing, even in 
asymptomatic individuals.  
 
6.1  Study population 
 
The study population of 112 subjects was divided into three groups according to specific age 
ranges to try and get a more even distribution for the study population seen in this study. 
Group 2 and 3 consisted of patients seen in a general cardiology practice and group 1, 
recruited at the local university, as a control group. Less female patients were seen because 
less than a third of the general cardiology practice where the study was performed is female. 
 
Clinical risk factors consisted of age, body composition, smoking, alcohol consumption, 
ischemia, hypertension and diabeties were included in the study.  The most profound changes 
on diastolic variables occurred related age and body composition. Clinically significant 
cardiovascular disease was not present at the time the study but the ischemia group included 
patients who had previous ischemic incidents but were treated. Neither the amount of 
cigarettes nor the degree of alcohol consumption was considered in this study. All the 
hypertensive patients were on treatment.  
 
Baseline characteristics of the 112 study subjects are summarised in table 5.1. The BMI 
increased with ageing, although the oldest group showed a decrease in BMI. It was clear that 
obesity played a significant role in all the groups and affected their diastolic variables. 
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6.2  Systolic variables  
 
Commonly used parameters of left ventricular systolic function are left ventricle ejection 
fraction, fractional shortening as well as mean circumferential shortening. Based on 
histological  studies the myocardium consists of circumferential fibres in the mid- wall and 
longitudinal fibers along the encocardial and epicardial layers (Grant, 1965; Greenbaum et 
al., 1981). Systolic function is determined by the sum of the contractions of these different 
fibres. 
 
This study demonstrated that no significant differences occurred in the systolic variables with 
the ageing process (Fig 5.5). Previous studies done on left ventricle ejection fraction with 
radionuclide methods suggested a slight increase in ejection fraction with ageing (Pfisterer et 
al., 1985).  
 
Age related changes in left ventricle systolic and diastolic function in clinically normal 
patients have also been described (Kitzman et al., 1991; Spirito et al., 1988). In these studies 
the isovolumetric relaxation time and the maximal late diastolic or A-wave flow velocity 
increased significantly with age. Changes specifically occurred in pulsed Doppler 
echocardiography (Kitzman et al., 1991 Spirito et al., 1988), in tissue Doppler imaging 
(Palka et al., 1996) and with radio nuclide angiography (Bonow et al., 1988). In this study we 
had similar findings (See Table 5.6). Conversely the E-peak flow velocity and the 
deceleration time in early diastole and the E/A-ratio decreased significantly with age. 
 
Another study  (Gertenblith et al. 1977) reported that left ventricle pump function in vivo is 
minimally affected by ageing, based on studies performed using M-mode echocardiography.  
No obvious changes were observed in ejection fraction, shortening fraction or mean 
circumferential fibre shortening in the abovementioned study. When considering that the 
stroke volume, stroke volume index, cardiac output and cardiac output index did change 
significantly, one can speculate that the reason for these changes can be found in the filling of 
the left ventricle and therefore the diastolic variables. 
 
The ejection time increased with age especially from group 1 to group 3. It can be speculated 
that the reason for this happening can be due to the larger stroke volume that was found with 
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ageing and therefore a longer time for ejection is necessary.  These findings are in agreement 
with previous studies which demonstrated that with ageing the left ventricle ejection time 
increased (Gardin et al., 1987; Wanderman et al., 1981).  
 
There was a notable increase in cardiac output with age (See Table 5.4). Since cardiac output 
is the product of stroke volume and heart rate, in our study results the cardiac output did not 
change therefore the only explanation could be found was that the atria contribution increased 
and therefore caused an increase in cardiac output. Stroke volume increased with ageing but 
the left ventricle contraction did not change thus, the explanation for the increased stroke 
volume could ascribed to the percentage atrial contribution or active filling that increased 
with ageing. Left-sided dimensions, left ventricle mass, and mass index, as well as the 
relative wall thickness of the study population increased with age (See Table 5.3). In previous 
studies an increase in myocardial fibrosis was found with age, together with increases in 
collagen tissue and myocardial mass (Gardin et al., 1979; Gertenblith et al., 1977; Yin et al., 
1980). The older population also showed more hypertrophied left ventricles even when 
indexed to body size. The internal dimension in systole and diastole demonstrated no 
significant abnormalities, even when considering that the stroke volume increased (Table 
5.4). 
 
The results of this study suggests that, the left ventricle became more proficient in ejecting its 
content with age without increased systolic variables and with a decrease in the longitudinal 
function of the left ventricle muscle fibres. It can be speculated that the reason for this 
increase in cardiac output can be related to significant changes that occur in the diastolic 
variables, especially the atrial contribution: In this study there was a progressive decrease in 
the passive filling of the left ventricle with age. Increasingly more abnormalities of diastolic 
variables were found in the older population (Table 5.6). 
 
The results of this study seems to indicate that the longitudinal fibers on the septal and the 
lateral walls became weaker with ageing (See table 5.5); while it seemed that the 
circumferential fibres stayed the same or even showed a slight increase in strength as 
demonstrated in this study. The tissue Doppler measurement of the muscle is independent of 
volume of the left ventricle and unaffected towards preload or afterload. It remains that, while 
cardiac output of the heart increases with age, the circumferential muscle stays the same and 
the longitudinal muscle becomes weaker with measureable  diastolic adaptations especially a 
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larger atrial contribution. Thus the heart becomes more effective without much change in the 
systolic variables. This study illustrates the necessity to evaluate the diastolic variables as part 
of the routine follow-up of cardiology patients. 
 
6.3  Diastolic variables   
6.3.1 Trans mitral flow  
 
Diastole can be divided into passive filling (E peak) and active filling (A peak). As the left 
ventricle ages or is affected by disease processes like hypertension and diabetes, the 
myocardial muscle becomes less effective and loses its ability to maintain stroke volume. 
 
Common causes for diastolic dysfunction are ageing, ischemia, myocardial fibrosis, altered 
collagen composition, hypertension and left ventricular hypertrophy. The diastolic pressure- 
volume relationship during passive steady state of the left ventricle is governed by elastic 
myocardial properties (compliance) and reflects the interaction between the intrinsic forces, 
resisting this stretching from within the myocardium. Elasticity represents the individual 
properties of muscle, extracellular matrix and coronary blood vessels. Changes in these 
properties can occur when the relative quantity of collagen increases such as with 
hypertrophy, fibrosis or with scar formation due to myocardial infarction or infiltrative 
deceases such as amyloid (Stevenson et al., 1989). 
 
In this study E peak diminished in velocity with ageing. The deceleration time of the E peak 
also prolonged with ageing. The velocity of the passive filling of the left ventricle decreased 
as the study population aged (Table 5.6). It also took longer for the left ventricle to fill with 
blood during the passive filling phase. Keeping in mind that the left ventricle mass also 
increased with age, it means that the left ventricle takes longer to fill at a decreased velocity 
after the mitral valve opens. In the younger group passive filling was rapid with less time 
used to fill the left ventricle. In this group the E peak was almost always higher than the A 
peak. Deceleration time or filling time was also shorter in the younger group (Table 5.6). It 
was described earlier that the stroke volume increased with ageing although the left ventricle 
mass increased but the ejection fraction stayed the same. Results seem to indicate that passive 
filling or the first filling phase played a progressively smaller role in the filling of the left 
ventricle with ageing (Table 5.6). 
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Active filling or atrial contraction played an increasingly more important role in filling of the 
left ventricle in order to attain the stroke volume or even increase it. This correlated with 
previous studies where it was found that left ventricular function, particularly left ventricular 
relaxation, becomes impaired with age, even in healthy patients (Bonow et al., 1988; Bryg et 
al., 1987; Iskandrian et al., 1986; Klein et al., 1994; Miyatake et al., 1984; Miller et al., 
1986; Spirito et al., 1988). This impairment manifested as a decrease in the early diastolic 
flow (E wave) and a compensatory increase in the atrial systolic flow velocity (A wave) 
(Bonow et al., 1988; Bryg et al., 1987; Iskandrian et al., 1986; Miyatake et al., 1984; Miller 
et al., 1986; Klein et al., 1994; Spirito et al., 1988). 
 
This study showed that the A velocity increased significantly with ageing. The younger group 
had very low A-wave peak velocities. Most of the filling of the left ventricle occurs in the 
passive phase in the younger group but with age it changes so that active filling or atrial 
contraction becomes the dominant phase (Table 5.6). This occurs because the left ventricle 
stiffens with age and the atrium starts to play an increasingly more important role maintaining 
the normal stroke volume it order to uphold a constant cardiac output. To attain a better atrial 
contraction the left atrium needs to work harder and hold more blood.  The left atrium 
enlarges due to increased work load and the larger effort needed to fill the left ventricle with 
blood. It was found in this study that left atrial size increased. In the younger group most of 
the filling occurred during passive filling so that less blood from the atrium was needed to fill 
the left ventricle. In the older group the left ventricle became stiffer with less passive filling 
of the left ventricle and more active filling. 
 
With ageing, there is a gradual decrease in the rate of myocardial relaxation as demonstrated 
by the increase in the deceleration time of the passive filling of the left ventricle (See Table 
5.6). With normal left atrial pressure, the pressure crossover between the left ventricle and the 
left atrium occurs later and early transmitral pressure gradient is decreased. Hence the 
isovolumetric time becomes longer and the E velocity in normal subjects gradually declines. 
The reduced filling in early diastole delays the pressure equilibration between the left 
ventricle and the left atrium, resulting in a longer deceleration time. More blood is thus 
needed from the atrium to fill the left ventricle. The left atrium needs to adapt to this need 
and subsequently becomes enlarged. However due to this increased volume the pressure in 
the left atrium also rises. This results in effect that the ratio between the E peak and the A 
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peak decreases. The younger group demonstrated E/A ratios higher than 1 and the older 
groups E/A ratios were almost always below 1, confirming the effect of passive filling 
against the progressively higher A-peak velocities with age (Table 5.6). 
 
It was demonstrated in previous studies that left ventricle function becomes impaired with 
ageing in healthy persons despite normal systolic function (Aronow et al., 1989; Gerstenblith 
et al., 1977; Pearson et al., 1991; Port et al., 1980).  It was also found that the peak E velocity 
of the transmitral flow decreases with age and the peak atrial systolic velocity increases with 
ageing, resulting in a decrease in their ratio (Bonow et al., 1988; Bryg et al., 1987; Iskandrian 
et al., 1986; Klein et al., 1994; Miyatake et al., 1984; Miller et al., 1986; Spirito et al., 1988). 
 
In experimental studies it was demonstrated that the myocardial fibre tension becomes greater 
with ageing, and the relaxation time is prolonged because of change in the active state 
properties (Lakatta et al., 1975; Schwartz et al., 1973; Weisfeldt et al., 1971). It is believed 
that the age-related decrease in diastolic function of healthy individuals is influenced not only 
by the impairment of the active myocardial relaxation, but also by increased left ventricle 
myocardial and chamber stiffness (Templeton et al., 1979). Furthermore, it was reported that 
nonuniformity of myocardial relaxation occurs in older patients (Bonow et al., 1988). It is 
thus clear that diastolic function should properly assessed in all patients. 
 
6.3.2 Myocardial velocities 
 
Since Greenbaum et al. (1981) have reported the importance to evaluate the longitudinal 
function of the myocardial fibres, left ventricular systolic and diastolic function with the use 
of mitral annular motion (by M-mode echocardiography) and the tissue velocity (by tissue 
Doppler echocardiography) have been employed to evaluate these variables. 
 
All moving objects intersected by ultra sound generate Doppler shift velocities. Tissue 
Doppler echocardiography analyses motion from relatively slow-moving reflectors such as 
left ventricular muscle. Traditional colour-flow Doppler evaluated relatively high velocity 
signals and “weak” ultrasound reflectors like red-blood cells (Kerut et al., 2004). 
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This study evaluated the diastolic variables of the lateral aspects as well as the septal motion 
of the left ventricular mitral valve annulus. The variables that were measured were the early 
diastolic motion (E’) and the late diastolic relaxation wave (A’). The measurement of these 
variables is not affected by the volume of the left ventricle and can be used to verify the 
presence of diastolic abnormalities. In this study significant decreases in the E’ at the lateral 
as well as the septal annulus were detected with ageing (Table 5.6).  The opposite happened 
with the A’ where there was a significant increase in velocity at the lateral and septal annulus 
with ageing. This decreased the E’/A’ ratio, especially of the lateral wall. In all the tissue 
Doppler variables measured, there were significant abnormalities illustrated with ageing 
(Table 5.7). It seems that the measurement of the TDI variables is important when analysing 
diastolic status of patients.  
 
The E’ at the lateral wall was greater than that of the septal wall, with the A’ the same at the 
lateral and the septal wall in patients without diastolic abnormalities. The ratios of the lateral 
wall were greater than that of the septal wall ratios (Table 5.6). The same findings were 
present in a study done by Peverill et al. (2004), who also found that the E’ were higher at the 
lateral than at the septal wall.  
E’ correlated with Torsion (Tau) suggesting that the E’ is a marker of left ventricle relaxation. 
It was found with the trans-mitral flow that left ventricle relaxation decreased. Also, with 
tissue Doppler of the lateral and septal wall, it was evident that the relaxation took longer 
with ageing. The reason why the E’ of the lateral wall is higher than that of the septal wall, 
may be found in a study done by Greenbaum et al. (1981) where they found that there are 
variations in the anatomy of the longitudinal myocardial fibres that run from the apex to the 
fibrous atrioventricular ring. He also found that these longitudinal fibres are mainly present in 
the subendocardial and sub epicardial layers of the left ventricular lateral wall and papillary 
muscles. Thus, there are fewer longitudinal fibres in the septal wall than in the lateral wall 
and the subepicardial longitudinal fibres also vary from the apical to the basal segments in the 
septum (Table 5.6). 
 
When evaluating diastole in patients it is not adequate to only measure trans-mitral flow, as 
this is volume dependant, thus giving a false impression of the diastolic profile of the patient. 
In addition, it is important to measure tissue velocities of the lateral and septal walls of the 
left ventricle since these measurements are not influenced by volume loading of the left 
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ventricle. It was also observed in this study that tissue Doppler differentiates patients with 
normal profiles from those with pseudo-normal profiles (Table 5.6) 
 
6.4  Risk factors 
 
As a clinical tool, echocardiography has been important in defining the prevalence and 
magnitude of clinical risk factors on the cardiovascular system. It has established its value in 
determining the effects of these risk factors on the heart in order to help physicians to treat 
patients. Having defined the pathophysiologic relevance of specific echocardiographic 
variables in normal patients, it was also necessary to look at the effects clinical risk factors 
may have on these variables. 
 
6.4.1 Group 1 
 
In Table 5.8 it is apparent that the most common risk factor for group 1 was smoking and 
alcohol consumption. It should be pointed out that the amount the subjects smoked was not 
being quantified in this study. No diastolic or systolic variables changed in group 1 due to 
smoking or alcohol consumption. Smoking and alcohol consumption was evaluated in 
combination with other risk factors like obesity, which had considerable effects on the 
diastolic variables measured in group 1. 
 
Significant increases were detected in the A velocity and the E/A ratio as well as the E’/A’ 
ratio of the septum and the lateral wall. In a study done by Di Bello et al (2006) significant 
differences were found between obese and control groups with regard to the peak A-flow 
velocity, which was higher in the obese group compared to the control group. As a 
consequence, the E/A ratio was also significantly lower in obese patients similar to our 
results. They also found that the E’/A’ ratios of the lateral and septal walls were negatively 
affected in the obese group. On tissue Doppler the only systolic variables in group 1 with 
obesity that increased were S’. This is probably due to the extra workload the left ventricle 
has in obese patients with increased muscle mass (see Table 5.3). Left ventricle mass 
increased considerably with obesity in group 1.  It should be pointed out that all combination 
risk factors were related to lifestyle in group 1. They were all smokers, consumed alcohol, 
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were overweight and had high cholesterol. No changes in any measured variable were found 
in group 1 with cholesterol as an isolated risk factor.  
 
A recent study done by Di Bello et al. (2006) revealed all myocardial diastolic phases were 
altered in obese patients. Their study demonstrated the negative effects obesity has on the 
muscle and postulated that this be mediated by insulin resistance. They found that: 
 Insulin may act as a growth hormone in the myocardium and hyperinsulinemia leads 
to increased left ventricle mass in rats (Holmang et al., 1996). 
 Hyperinsulinemia may lead to sodium retention that could cause a subclinical left 
ventricle myocardial dysfunction as a result of volume expansion (De Fronzo et al., 
1975). 
 Hyperinsulinemia may lead to sympathetic nervous system activation (Anderson et 
al., 1991). 
 Insulin resistance is related to an increased pressor response to angiotensin II, which 
stimulates left ventricular hypertrophy and causes interstitial fibrosis (Gaboury et al., 
1994). 
Forty-one percent of this group 1 was overweight and this should be regarded as significant 
when considering risk stratification for future cardiac events. When considering that even as 
the youngest group, obese indivuduals already showed diastolic changes, especially in the 
TDI variables where muscle is measured and not the volume differences (Table 5.8). 
 
6.4.2 Group 2  
 
The most common risk factor for group 2 was obesity. Seventy-one percent of this group 
were overweight (see Table 5.2). Smoking and alcohol consumption was not as important. 
Other risk factors included in this study started to play an increasingly important role in this 
group. Considering what Di Bello et al. (2006) found in their study, (as described in 6.5.1 
about the effects of obesity on the heart muscle), it is apparent that similar abnormalities were 
present in this study. 
 
Other risk factors that started to play an increasingly important role were hypertension (46%), 
cholesterol (52%), ischemia (40%), and diabetes (8%). The combination of risk factors also 
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increased in group 2 with more patients having more combinations of risk factors. Again, as 
in group 1, the lifestyle risk factors such as obesity, cholesterol and hypertension were 
prominent. Obesity became more relevant in this group with diastolic abnormalities as seen in 
Table 5.6.   
 
Although the risk factors played an important role in group 2 with regard to risk stratification, 
only the E’/A’ ratio of the lateral wall showed significant changes in the overweight group.       
In patients who had hypertension, A-peak velocity increased significantly, This could be due 
to increased left ventricle mass in hypertensive patients with associated increases in wall 
stiffness. In the smoking group A-peak velocity also increased significantly, as were the case 
with the cholesterol group (Table 5.8).  
 
These changes may be due to the combination of ageing and certain risk factors. In previous 
studies it was observed that reservoir function of the LA were reduced with ageing (Barbier 
et al., 1999; Spencer et al., 1998; Spencer et al., 2001). Several studies have reported that the 
LA booster function is augmented with age and that the active emptying (A velocity) 
percentage of total emptying which is a marker of LA booster function,  had a significant 
positive correlation with age (Anwar et al., 2007;  Spencer et al., 1998;  Spencer et al., 2001; 
Triposkiadis et al., 1995). 
 
The Tei index decreased in subjects who had diabetes in group 2. This can be due to diastolic 
changes that occur in diabetic patients as reported in a study performed by Annonu et al. 
(2001) where it was found  that diabetic patients had lower mean E velocities and a lower 
deceleration slope than their control group. The same was found in this study with lower E 
velocities in the diabetic group although not significant lower (Table 5.14).   
 
6.4.3 Group 3  
 
The most common risk factor for group 3 was hypertension and ischemia with a prevalence 
of 75% (Fig 5.6). As in group 2, obesity also was a prevalent risk. Risk factors associated 
with life style were very prominent with both ageing and obesity playing an increasingly 
important role in this group. Diastolic abnormalities were present in this group. Hypertension 
and diabetes were more frequent in this group with more abnormal lifestyle risk factors.  The 
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combination of risk factors that patients in this group displayed differed from group 1, with a 
higher incidence of ischemia and diabetes in patients with a combination of four or more risk 
factors (Fig 5.6).  
 
No significant echocardiographic changes occurred in these risk groups and it followed a 
similar pattern as in the other groups where diastolic changes occur in specific risk groups 
due to the underlying pathophysiology. It seems that an equilibrium where no more changes 
occur is reached and the cardiac system equilibrates. 
 
Only ischemia as risk factor prolonged the Tei index significantly in group 3.  A velocities 
decreased with ischemia in group 3. Definite muscle changes occurred with both the lateral 
and septal walls E’/A’ ratio increased in subjects with ischemia. This was due to a decreased 
E’. 
   
In previous studies it was found that patients who had myocardial infarction, S’ and the E’ 
velocities were decreased even at rest (Duncan et al., 2001; Yu et al., 2007). The same were 
found in this study with the S’ and E velocities decreased in patients who had ischemic events 
(Table 5.13).  
 
6.5  Study limitations  
 
Although thorough scientific rules and methods were employed in the execution of this study 
it is important to notice the limitations that might affect the results found in this study.                
The subjects of this study were not randomly selected because we wanted to look at the 
profile of patients presented at a general cardiology practice. The majority of the patients 
were male because dominantly male patients are seen at this specific cardiology practice. 
Most of the patients included in this study were Caucasian because few patients of other races 
were seen during the study period.  
 
In this study the control group was younger. In reality, it is difficult to age-match normal 
control subjects to patients with impaired diastolic function because age itself is a cause of 
delayed left ventricular function. No attempt was made to assess the possible influence of 
medication on the diastolic and systolic variables measured in this study. 
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Myocardial ischemia because of coronary artery disease could not be ruled out as no coronary 
angiography was performed. However, all patients were free of angina. No effort was made 
to quantify alcohol consumption. This may cause discrepancies in the measurement with 
relation due to volume changes that may occur. Also, the degree of smoking was not 
determined. 
 
Measurements of BMI were made on the basis of length and weight measurement and fat 
mass and percentage were not considered which may have an effect due to different body 
profiles in this study. It might be necessary in future studies of this kind to evaluate the 
somatotype of the study population in order to better determine the effect of obesity. It should 
also be pointed out that it was time-consuming doing all these systolic and diastolic variables 
and might play a role in a busy cardiology practice.  
 
6.6  Conclusion 
 
The study assessed left ventricular diastolic and systolic variables in 112 subjects divided in 
three age groups using echocardiography, Doppler echocardiography as well as tissue 
Doppler echocardiography. Two specific goals were specified in this study. The first goal 
was to determine what effect age has on these systolic and diastolic variables amongst the 
general South African population. In addition it was the author’s intension to evaluate which 
effects certain clinical risk factors may have on these variables. It was clear in this study that 
the systolic component of the examination did not change much. Velocity of the longitudinal 
fibres decreased with advancing age but the circumferential fibres almost stayed the same. No 
abnormalities were detected in ejection fraction, shortening fraction and mean circumferential 
shortening except where ischemia was detected. 
 
Increases were detected in the stroke volume of the subjects as well as the cardiac output. It 
was speculated that this might be due to changes in diastole. This was confirmed with almost 
all the diastolic variables changing with age. The transmitral E peak decreased in velocity 
with age and the deceleration time increased, indicating that the left ventricle becomes less 
compliant with age. However, the A velocity increased with advancing age. It was apparent 
that with advancing age the atrium starts to play a more active role in the filling of the left 
ventricle in order to maintain a normal or even increased stroke volume and cardiac output. 
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These age-related transitional changes in diastolic function were similar in the whole study 
population surveyed, and confirmed the necessity of evaluating patients in a general 
cardiology practice for abnormalities in diastole. It was found that the E peak decreased with 
advancing age, with a subsequent increase in the atrial velocity. It is important to measure the 
ratios of the trans-mitral flow as well as the tissue Doppler velocities as a minimum 
examination.  
 
Obesity was the most important clinical risk factor and had the most profound effect on all 
the subjects. Obesity played an important role in abnormalities found in the study population, 
especially the diastolic variables. It was observed that in the obese group abnormalities in 
diastole were more profound compared to the normal weight group (See Table 5.6). The 
second major finding of this study was that obesity is an important problem amongst affluent 
South African population with profound effects on the patient’s heart health. Life style 
changes should be considered for better health status of patients seen in a general cardiology 
practice.  
 
However, if abnormalities are detected in these ratios a thorough examination should be 
done. Abnormalities in diastolic variables in this study were detected looking at the ratios of 
the trans-mitral flow as well as Doppler echocardiography. Another important variable that 
should be included in an echocardiographic evaluation should be the IVRT because it also 
showed significant increase with age and especially in obesity. Special attention should be 
paid to the measurement of the A peak as it related to various abnormalities in the ischemic 
group as well as with ageing. The A peak showed an important increase in the ageing 
subjects.  
 
In conclusion, this study emphasized the profound effect ageing and obesity have on the 
systolic and diastolic variables of  patients and the importance of measuring these 
abnormalities as part of the general echocardiographic examination, especially since this is 
not routinely done in most practices in South Africa.  
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6.7  Recommendations  
 
Future aims should focus on constructing a practical time-friendly algorithm for evaluating 
left ventricular diastolic function, utilising the combination of age-adjusted values for trans 
mitral flow velocities as well as tissue Doppler velocities to be done on all patients seen in a 
general cardiology practice. In addition, further studies could be aimed at the obesity problem 
and the negative effects it has on cardiology patients and what effect lifestyle changes may 
have on these patients’ diastolic and systolic profiles. 
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Appendix A 
Patient Information Form 
 
INFORMATION DOCUMENT     Datum:_____ 
Title of study:  A comparative study of the systolic and diastolic components of the cardiac cycle of 
Caucasian patients with abnormal muscle performance index against patients with normal muscle 
performance index. 
 
Welcome ladies and gentlemen and thank you for having me to tell to about our research study. 
 
We, Prof. E van den Heever-Kriek and Mnr. JJ Steyn are doing research on muscle performance index of the 
heart muscle. In this study we want to learn about “the muscle performance index of the heart”. The study 
involves measurement of the time intervals of the heart with echocardiography to determine if the functionality 
of the heart’s performance is influenced. This means that we are going to measure systole (contraction) and 
diastole (relaxation) of the heart with Doppler (sound waves) and use this information in a formula to determine 
if the heart is working properly. By knowing this we can also determine which part of the heart’s systole 
(contraction) or diastole(relaxation) is causing problems for the normal functioning of the heart. The study is 
aimed at 120 male or female South African patients that must undergo routine cardiological examination. 
 
 I should like to point out to you that this is a study involving research and not routine care. Your participation 
in the study will not affect your routine medical care in anyway. We are therefore asking you to participate in 
this research study. For this study to take place, we will need you to consent to the following: 
 That your routine echocardiography information would be made available to Prof. E van den Heever and 
Mr. JJ Steyn for the sole purpose of the research study. 
 That muscle performance index may be done as part of the echocardiography examination. 
The research project is very safe. There should be no safety concerns regarding the echocardiogram because it is 
part of your normal consultation. Also note that, you will not be paid for your participation in this study. 
 
Your participation in the study is voluntary, and your refusal to participate will involve no penalty or loss of 
medical benefits to which you are otherwise entitled. You are at liberty to withdraw from this project at any 
stage without giving reasons. Your withdrawal will not be held against you, and your consultations and 
treatment with your physician will continue as if you were never enrolled in the project. 
 
The confidentiality of this study is of utmost importance. Efforts will be made to treat your medical records 
confidentially, but absolute confidentiality cannot be guaranteed. Personal information may be disclosed if 
required by law. The Ethics Committee for Medical research may also inspect and/or copy your research records 
for quality assurance and data analysis. Publication of the results of this study will in no way lead to individual 
or cohort identification.  
 
You may contact us any time if you have questions about the research or if you are injured as a result of the 
research. 
 
Contact Details of the Researchers:  
         Prof. E van Heever-Kriek: (0827705356) 
 Mr. JJ. Steyn: (0823712887) 
 
You may also contact the Secretariat of the Ethics Committee of the Faculty of Health Sciences, UFS at 
telephone number  
(051) 405 2812 if you have questions about your rights as a research subject. 
We thank you very much for your cooperation 
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INLIGTINGDOKUMENT         Datum:   
 
Titel van die studie: ‘n Vergelykende studie tussen  die sistoliese en diastoliese  komponente  van die kardiale siklus 
van  blanke pasiente met abnormale  spier  funksionaliteit  indeks teenoor pasiente met normale spier funksionaliteit  
indeks. 
Welkom by hierdie studie dames en here en dankie vir die geleentheid om julle in te lig aangaande hierdie studie. 
Ons , Prof E van den Heever –Kriek  en Mnr J.J. Steyn is besig met navorsing oor die spierfunksionaliteit indeks van die 
hart. In hierdie studie wil ons meer leer aangaande die hartspier funksionaliteits indeks. 
Die studie behels die meting van tyds-intervalle van die hartsiklus met eggodardiograpfie (hart sonar) om te bepaal wat die 
funksionaliteits indeks van die hart beinvloed. Dit beteken dat ons sistool (sametrekking) en diastool (ontspanning) van die 
hart deur middel van Doppler (klankgolwe) gaan meet en die informasie wat ons kry sal gebruik om te bepaal of die hart 
normaal funksioneer. 
Deur hierdie kennis te vergader sal ons kan bepaal watter deel van die hart se sistool of diastool verantwoordelik is vir 
probleme aangaande die normale funksionering van die hart. Die studie beplanning sluit in 120 manlike en vroulike Suid 
Afrikaanse patiënte wat roetine kardiologie ondersoeke moet ondergaan. 
Ek wil dit onder U aandag bring dat hierdie ‘n navorsingstudie is en nie roetine evaluasie nie. U deelname aan die studies al 
nie u roetine mediese sorg op enige manier beinvloed nie. Dis waarom ons u vra om deel te neem aan hierdie studie. Om aan 
die studie deel te neem moet u toestemming tot die volgende verleen. 
 Dat u roetine eggokardiografiese data aan die navorsers Prof E van den Heever asook Mnr  JJ Steyn vir die 
uitsluitlike doel van hierdie navorsing bekend gemaak mag word. 
 Dat die spier funksionaliteits indeks gedoen mag word as deel van die eggokardiografiese ondersoek. 
 
Die navorsings projek is baie veilig vir U as pasiënt. Die doen van die eggokardiogram is veilig vir u aangesien dit deel 
uitmaak van die normale konsultasie hartsonar.  Neem ook kennis dat U nie vergoed sal word om deel te neem aan hierdie 
studie nie. 
U deelname aan hierdie studie is dus vrywillig en indien u sou verkies om nie deel te neem aan die studie nie sal u geen van 
die normale mediese voordele verbeur nie. U mag enige tyd van die studie onttrek sonder om enige rede te verskaf. U 
ontrekking van die studie sal nie teen u gehou word nie en U konsultasie en behandeling by die kardioloog  sal voortduur 
asof u nooit aan die studie deelgeneem het nie. 
Die konfidensialiteit aangaande hierdie studie is van uitstaande belang. Daar sal stappe geneem word om u mediese rekords 
konfidensioneel te hanteer  maar absolute konfidensialiteit  kan nie gewaarborg word nie. Persoonlike inligting moet verskaf 
word indien ‘n hof so beslis. Die Etiese komitee vir mediese navorsing mag ook die navorsings data inspekteer en/of die 
navorsings data dupliseer vir gehalte versekering asook om die data te analiseer. 
Indien die navorsing gepubliseer word sal U naam beslis nie bekend gemaak word nie. 
 
Ons bedank u hartlik vir u samewerking.  Ons beantwoord graag enige van u vrae. 
Kontakbesonderhede van die Navorsers: –  
Prof E van den Heever-Kriek (Projekleier/Studieleier) Cell nr: 082 770 5356   
Mnr. JJ. Steyn (Navorser) Cell nr: 082 3712887 
Kontakbesonderhede van NEK Sekretariaat en Voorsitter – vir rapportering van klagtes/probleme 
Telefoonnommer:  051-405 2812  
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Appendix B 
Patient Consent Form 
CONSENT TO PARTICIPATE IN RESEARCH 
You have been asked to participate in a research study; “ 
 
You have been informed about the study by Mr. JJ. Steyn. 
You may contact any of the following people any time if you have questions about the research or if you are 
injured as a result of the research. 
Prof. WMJ van den Heever-Kriek at 082 7705356 (Project leader/Study leader) 
Mr JJ Steyn at 0823712887 (Researcher) 
 
You may also contact the Secretariat of the Ethics Committee of the Faculty of Health Sciences, University of 
the Free State at telephone number (051) 4052812 if you have questions about your rights as a research subject. 
 
Your participation in this research is voluntary, and you will not be penalized or lose benefits if you refuse to 
participate or decide to terminate participation.   
 
If you agree to participate, you will be asked to fill a questionnaire and you will also be given a copy of this 
document as well as the participant information sheet, which is a written summary of the research. 
 
“The research study, including the above information has been verbally described to me.  I understand what my 
involvement in the study means and I voluntarily agree to participate”.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_____________________   __________________ 
Signature of Participant   Date 
 
 
 
 
_____________________   __________________ 
Signature of Witness   Date 
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Toestemming tot deelname aan navorsing 
 
U is gevra om deel te neem aan die navorsingstudie “n Vergelykende studie tussen  die sistoliese en diastoliese  
komponente  van die kardiale siklus van  blanke pasiente met abnormale  spier  funksionaliteit  indeks teenoor 
pasiente met normale spier funksionaliteit  indeks”. 
U is ingelig aangaande die studie deur Mr JJ Steyn. 
U mag enige van die volgende mense skakel indien U enige vrae aangaande die navorsing studie het of as U ‘n 
besering opdoen as gevolg van die navorsing. 
Prof  WMJ van den Heever-Kriek at 082 7705356 (Studie leier) 
Mr JJ Steyn at 0823712887 (Navorser) 
U kan die Sekretariaat van die Etiekkomitee van die Fakulteit Gesondheidsweteskappe, UV by telefoonnommer 
(051) 4052812 kontak indien u enige vrae het oor u regte as ‘n proefpersoon. 
 
U deelname aan die studie is vrywillig en U sal nie gepenaliseer word of enige voordele verloor indien U sou 
besluit om nie verder aan die studied eel te neem nie. 
 
Indien U sou besluit om deel te neem sal U gevra word om die vorm te onderteken en ‘n kopie van die inligtings 
vorm sal aan U oorhandig word. Hierdie is ‘n opsomming van die navorsings projek.  
 
Die navorsings studie asook die bogenoemde informasie is verbaal aan my verduidelik. Ek verstaan wat my doel 
in die studie is en gee toestemming om deel te neem aan die studie.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_____________________   __________________ 
Handtekening van pasient   Datum 
 
 
 
 
_____________________   __________________ 
Handtekening van navorser  Datum 
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Appendix C 
Echocardiography Data Sheet 
 
DATA SHEET 
 
 
SUBJECT’S RESEARCH NUMBER  
AGE  
WEIGHT  
LENGHT  
B.S.A.  
B.M.I.  
HEART RATE  
MALE OR FEMALE  
 
EJECTION FRACTION         
SHORTENING FRACTION   
MEAN SIRCUMFERENTIAL SHORTENING  
EJECTION TIME  
SEPTUM DIMENSION SYSTOLE   
SEPTUM DIMENSION DIASTOLE  
POSTERIOR WALL THICKNESS SYSTOLE  
POSTERIOR WALL THICKNESS DIASTOLE  
LEFT VENTRICLE INTERNAL DIMENSION SYSTOLE  
LEFT VENTRICLE INTERNAL DIMENSION DIASTOLE  
LEFT ATRIAL DIMENSION  
RELATIVE WALL THICKNESS  
LEFT VENTRICLE MASS  
LEFT VENTRICLE MASS INDEX  
STROKE VOLUME   
STROKE VOLUME INDEX  
CARDIAC OUTPUT  
CARDIAC INDEX  
 
 
TRANS MITRAL E VELOCITY  
TRANS MITRAL A VELOCITY  
DECELERATION TIME  
E/A RATIO  
ISOVOLUMETRIC RELAXATION TIME  
ANNULAR E TDI  SEPTUM  
ANNULAR A TDI  SEPTUM  
EM/AM RATIO SEPTUM  
ANNULAR SM SEPTUM  
ANNULAR E TDI POSTERIOR  
ANNULAR A TDI POSTERIOR  
EM/AM RATIO POSTERIOR   
ANNULUR SM POSTERIOR  
 
M TO M DISTANCE   
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Notes 
 
  
 
 
 
 
 
 
 
 
